https://pharmadigest.net/en/https://pharmadigest.net/en/archive/https://pharmadigest.net/en/archive/2026/https://pharmadigest.net/en/archive/2026/08/https://pharmadigest.net/en/archive/2026/09/https://pharmadigest.net/en/archive/2026/10/https://pharmadigest.net/en/articles/2026-08-31-alnylam-astrazeneca-wainua-attr-cm-trial-failure/https://pharmadigest.net/en/articles/2026-08-31-genentech-dualitybio-adc-payload-deal/https://pharmadigest.net/en/articles/2026-09-01-novartis-bms-autoimmune-car-t-trial-pause/https://pharmadigest.net/en/articles/2026-09-02-alumis-envudeucitinib-lupus-trial-miss/https://pharmadigest.net/en/articles/2026-09-02-eli-lilly-merida-biosciences-acquisition/https://pharmadigest.net/en/articles/2026-09-02-novartis-remibrutinib-multiple-sclerosis-phase3/https://pharmadigest.net/en/articles/2026-09-02-uniqure-amt130-huntingtons-bla-submission/https://pharmadigest.net/en/articles/2026-09-03-arpa-h-rna-manufacturing-give-program-funding/https://pharmadigest.net/en/articles/2026-09-03-fiz1-molecular-glue-thalidomide-degrader/https://pharmadigest.net/en/articles/2026-09-03-gsk-mrna-flu-vaccine-phase3-dual-ha-na/https://pharmadigest.net/en/articles/2026-09-03-roche-simcere-zaiming-sim0660-trispecific-license/https://pharmadigest.net/en/articles/2026-09-03-tscan-therapeutics-workforce-cut-solid-tumor-pivot/https://pharmadigest.net/en/articles/2026-09-03-ultragenyx-angelman-apazunersen-phase3-failure/https://pharmadigest.net/en/articles/2026-09-11-aerobactin-aztreonam-siderophore-conjugate/https://pharmadigest.net/en/articles/2026-09-11-astrazeneca-tozorakimab-copd-phase3/https://pharmadigest.net/en/articles/2026-09-11-bayer-hyrnuo-fda-approval-expansion/https://pharmadigest.net/en/articles/2026-09-11-ctmd-metadynamics-hit-triage/https://pharmadigest.net/en/articles/2026-09-11-dt-9081-ep4-receptor-antagonist/https://pharmadigest.net/en/articles/2026-09-11-elix-axcelead-tpd-partnership/https://pharmadigest.net/en/articles/2026-09-11-g-quadruplex-parp1-transcriptional-silencer/https://pharmadigest.net/en/articles/2026-09-11-grp78-isoform-selective-inhibitor-d2b/https://pharmadigest.net/en/articles/2026-09-11-hdac8-protac-compact-2in1-degrader/https://pharmadigest.net/en/articles/2026-09-11-kura-oncology-caspian-therapeutics-spinoff/https://pharmadigest.net/en/articles/2026-09-11-novartis-del-desiran-dm1-phase3-failure/https://pharmadigest.net/en/articles/2026-09-11-novartis-pelacarsen-lpa-horizon-failure/https://pharmadigest.net/en/articles/2026-09-11-novo-nordisk-ziltivekimab-trials-halted/https://pharmadigest.net/en/articles/2026-09-11-p53-mutant-covalent-stabilizer-rvjb59/https://pharmadigest.net/en/articles/2026-09-11-phopex-binding-to-release-conjugate-chemistry/https://pharmadigest.net/en/articles/2026-09-11-schrodinger-tectora-immunology-license/https://pharmadigest.net/en/articles/2026-09-11-siglec-7-bicyclic-peptide-inhibitors/https://pharmadigest.net/en/articles/2026-09-11-tri-611-alk-molecular-glue-degrader/https://pharmadigest.net/en/articles/2026-09-11-twostep-therapeutics-series-a-ts-104/https://pharmadigest.net/en/articles/2026-09-11-virtual-screening-benchmark-resolution-limits/https://pharmadigest.net/en/articles/2026-09-12-astrazeneca-etcamah-ctdna-guided-approval/https://pharmadigest.net/en/articles/2026-09-12-biomarin-voxzogo-hypochondroplasia-phase3/https://pharmadigest.net/en/articles/2026-09-12-cd38-cns-penetrant-tricyclic-inhibitors/https://pharmadigest.net/en/articles/2026-09-12-evommune-evo756-atopic-dermatitis-failure/https://pharmadigest.net/en/articles/2026-09-12-kalirin-rac1-molecular-glue-inhibitor/https://pharmadigest.net/en/articles/2026-09-12-mapvis-antibiotic-virtual-screening/https://pharmadigest.net/en/articles/2026-09-12-tideglusib-nata-chemical-probe/https://pharmadigest.net/en/articles/2026-09-13-astrazeneca-camizestrant-serena-4-trial-miss/https://pharmadigest.net/en/articles/2026-09-13-b3gat3-first-in-class-hepatocellular-carcinoma-inhibitors/https://pharmadigest.net/en/articles/2026-09-13-hiv-1-nnrti-entrance-channel-optimization/https://pharmadigest.net/en/articles/2026-09-13-oral-glp-1-small-molecule-blueprint/https://pharmadigest.net/en/articles/2026-09-13-pfama1-cryptic-loop-antimalarial-design/https://pharmadigest.net/en/articles/2026-09-13-scholar-rock-apitegromab-sma-fda-approval/https://pharmadigest.net/en/articles/2026-09-13-shionogi-cefiderocol-australia-approval/https://pharmadigest.net/en/articles/2026-09-13-sufex-dna-encoded-macrocyclic-peptide-libraries/https://pharmadigest.net/en/articles/2026-09-13-vav1-molecular-glue-ai-protein-folding/https://pharmadigest.net/en/articles/2026-09-14-akr1b10-inhibitors-boltz2-cofolding/https://pharmadigest.net/en/articles/2026-09-14-homocamptothecin-adc-payload/https://pharmadigest.net/en/articles/2026-09-14-solstice-oncology-harbour-biomed-ctla4-licensing/https://pharmadigest.net/en/articles/2026-09-15-biohaven-sk-biopharmaceuticals-opakalim-clinical-hold/https://pharmadigest.net/en/articles/2026-09-15-bioxcel-teva-bankruptcy-asset-sale/https://pharmadigest.net/en/articles/2026-09-15-definium-lsd-anxiety-phase3-fda-filing/https://pharmadigest.net/en/articles/2026-09-15-hts-mcu-activator-cardiac-bioenergetics/https://pharmadigest.net/en/articles/2026-09-16-akeso-summit-ivonescimab-keytruda-survival/https://pharmadigest.net/en/articles/2026-09-16-biontech-oncoc4-gotistobart-lung-cancer-survival/https://pharmadigest.net/en/articles/2026-09-16-bridgebio-oncology-kras-bbo8520-narrowing/https://pharmadigest.net/en/articles/2026-09-16-chemberta-casp4-virtual-screening-alzheimers/https://pharmadigest.net/en/articles/2026-09-16-crbn-molecular-glue-wbp4-degrader/https://pharmadigest.net/en/articles/2026-09-16-cyclic-peptide-protacs-hif1a-vhl-degrader/https://pharmadigest.net/en/articles/2026-09-16-gpr41-endotoxemia-autophagy-target/https://pharmadigest.net/en/articles/2026-09-16-merck-kgaa-postera-fertility-acquisition/https://pharmadigest.net/en/articles/2026-09-16-photoactive-parp1-inhibitors-computational-design/https://pharmadigest.net/en/articles/2026-09-16-reactive-metallo-scaffolds-prmt1-target-id/https://pharmadigest.net/en/articles/2026-09-16-thrombin-inhibitor-dynamic-combinatorial-chemistry/https://pharmadigest.net/en/articles/2026-09-16-trim24-bromodomain-nonhistone-interactome/https://pharmadigest.net/en/articles/2026-09-16-vera-trutakna-igan-origin3-phase3/https://pharmadigest.net/en/articles/2026-09-17-bmtac-bbb-permeable-tpd-aging-brain/https://pharmadigest.net/en/articles/2026-09-17-chemberta-ai-screening-casp4-inhibitors/https://pharmadigest.net/en/articles/2026-09-17-ctlh-mkln1-e3-ligase-degron-recognition/https://pharmadigest.net/en/articles/2026-09-17-encoded-therapeutics-series-f-dravet-gene-therapy/https://pharmadigest.net/en/articles/2026-09-17-gsk-chimagen-trispecific-tce-multiple-myeloma/https://pharmadigest.net/en/articles/2026-09-17-h-phosphonate-oligonucleotide-sar-platform/https://pharmadigest.net/en/articles/2026-09-17-hces2a-nir-fluorogenic-probe-inhibitor-discovery/https://pharmadigest.net/en/articles/2026-09-17-merck-rahway-layoffs-pipeline-cuts/https://pharmadigest.net/en/articles/2026-09-17-pyridine-chemoselective-bioconjugate-platform/https://pharmadigest.net/en/articles/2026-09-17-usp7-targeted-protein-stabilization-screening/https://pharmadigest.net/en/articles/2026-09-17-vera-trutakna-iga-nephropathy-phase3/https://pharmadigest.net/en/articles/2026-09-17-wbp4-crbn-molecular-glue-degrader/https://pharmadigest.net/en/articles/2026-09-18-astrazeneca-enhertu-nhs-england-nice-pricing-deal/https://pharmadigest.net/en/articles/2026-09-18-biontech-oncoc4-gotistobart-phase3-nsclc/https://pharmadigest.net/en/articles/2026-09-18-cmyc-ribotac-linker-optimization/https://pharmadigest.net/en/articles/2026-09-18-cyp8b1-quinoline-inhibitors-metabolic-disease/https://pharmadigest.net/en/articles/2026-09-18-flavonoid-bioisosteric-aromatase-inhibitors/https://pharmadigest.net/en/articles/2026-09-18-hdac4-hdac7-isoform-selective-th17-inhibitors/https://pharmadigest.net/en/articles/2026-09-18-keap1-nrf2-cofolding-screening-cascade-benchmarks/https://pharmadigest.net/en/articles/2026-09-18-merck-kgaa-postera-fertility-acquisition/https://pharmadigest.net/en/articles/2026-09-18-novo-nordisk-ascendis-glp1-deal-termination/https://pharmadigest.net/en/articles/2026-09-18-p38delta-self-encapsulating-kinase-inhibitor/https://pharmadigest.net/en/articles/2026-09-18-sellas-regal-trial-aml-expected-failure/https://pharmadigest.net/en/articles/2026-09-18-sionna-layoffs-cystic-fibrosis-trial-failure/https://pharmadigest.net/en/articles/2026-09-18-sling-therapeutics-series-c-linsitinib/https://pharmadigest.net/en/articles/2026-09-18-stellar-fragment-based-peptide-docking/https://pharmadigest.net/en/articles/2026-09-18-taar1-agonists-structure-based-discovery/https://pharmadigest.net/en/articles/2026-09-18-thrombin-inhibitor-dynamic-combinatorial-chemistry/https://pharmadigest.net/en/articles/2026-09-18-trim24-bromodomain-nonhistone-interactome/https://pharmadigest.net/en/articles/2026-09-19-ariadne-bio-parkinsons-apathy-launch/https://pharmadigest.net/en/articles/2026-09-19-astrazeneca-enhertu-nice-england-pricing/https://pharmadigest.net/en/articles/2026-09-19-hdac4-hdac7-selective-inhibitors-th17/https://pharmadigest.net/en/articles/2026-09-19-hyreptaones-cav31-calcium-channel-inhibitors/https://pharmadigest.net/en/articles/2026-09-19-jacs-degrader-antibody-conjugate-tumor-stroma/https://pharmadigest.net/en/articles/2026-09-19-keap1-nrf2-virtual-screening-stress-test/https://pharmadigest.net/en/articles/2026-09-19-kinase-catalytic-cluster-residues-structural-survey/https://pharmadigest.net/en/articles/2026-09-19-longeveron-elpis-ii-phase2b-failure/https://pharmadigest.net/en/articles/2026-09-19-north-immunology-aethlon-reverse-merger/https://pharmadigest.net/en/articles/2026-09-19-omaveloxolone-sting-degrader-repurposing/https://pharmadigest.net/en/articles/2026-09-19-scope-chemical-space-hit-finding/https://pharmadigest.net/en/articles/2026-09-19-sellas-regal-aml-trial-outlook/https://pharmadigest.net/en/articles/2026-09-19-sling-therapeutics-series-c-thyroid-eye-disease/https://pharmadigest.net/en/articles/2026-09-19-ultragenyx-fayuvi-sanfilippo-approval/https://pharmadigest.net/en/articles/2026-09-21-bms-orum-orm6151-degrader-antibody-conjugate-discontinued/https://pharmadigest.net/en/articles/2026-09-21-hdac-tumor-conditional-conjugate-panobinostat/https://pharmadigest.net/en/articles/2026-09-21-hsc70tac-chaperone-mediated-autophagy-degrader/https://pharmadigest.net/en/articles/2026-09-21-nav18-benzimidazole-tetrahydrofuran-pain-inhibitor/https://pharmadigest.net/en/articles/2026-09-21-novartis-lifonebart-als-phase2-failure/https://pharmadigest.net/en/articles/2026-09-21-novo-nordisk-rebrand-novo/https://pharmadigest.net/en/articles/2026-09-21-pi3ka-h1047r-mutant-selective-inhibitor/https://pharmadigest.net/en/articles/2026-09-21-reaps-geometric-deep-learning-peptide-design/https://pharmadigest.net/en/articles/2026-09-21-roche-genentech-boston-innovation-center/https://pharmadigest.net/en/articles/2026-09-21-shp2-lysine-covalent-fragment-allosteric-latch/https://pharmadigest.net/en/articles/2026-09-21-vhl-protac-egfr-degrader-nsclc/https://pharmadigest.net/en/articles/2026-09-22-alkermes-alks7290-orexin-adhd-phase1b/https://pharmadigest.net/en/articles/2026-09-22-aoh1996-pcna-second-generation-analogues/https://pharmadigest.net/en/articles/2026-09-22-biontech-genentech-cevumeran-colorectal-trial-halt/https://pharmadigest.net/en/articles/2026-09-22-caspase1-dihydropyridine-antagonists/https://pharmadigest.net/en/articles/2026-09-22-ck1delta-nras-melanoma-degrader/https://pharmadigest.net/en/articles/2026-09-22-del-ml-physics-generalizability-benchmark/https://pharmadigest.net/en/articles/2026-09-22-hbv-capsid-ai-multi-objective-optimization/https://pharmadigest.net/en/articles/2026-09-22-hutchmed-gsk-kras-egfr-attc-license/https://pharmadigest.net/en/articles/2026-09-22-muscarinic-m3-histamine-h1-bifunctional-rhinitis/https://pharmadigest.net/en/articles/2026-09-22-novo-nordisk-capital-markets-day-2030-strategy/https://pharmadigest.net/en/articles/2026-09-22-parp1-ck2a-dual-inhibitor-hrd-independent/https://pharmadigest.net/en/articles/2026-09-22-protac-oral-absorption-computational-score/https://pharmadigest.net/en/articles/2026-09-22-telix-itm-isotope-merger/https://pharmadigest.net/en/articles/2026-09-23-ai-driven-hbv-capsid-assembly-modulator/https://pharmadigest.net/en/articles/2026-09-23-alkermes-orexin-agonist-adhd-phase1b/https://pharmadigest.net/en/articles/2026-09-23-antibody-hotspot-peptide-influenza-fusion-inhibitors/https://pharmadigest.net/en/articles/2026-09-23-aoh1996-analogues-pcna-inhibitor/https://pharmadigest.net/en/articles/2026-09-23-caspase-1-dihydropyridine-antagonists/https://pharmadigest.net/en/articles/2026-09-23-ck1delta-degrader-nras-melanoma/https://pharmadigest.net/en/articles/2026-09-23-covalent-bax-inhibitor-cytoprotection/https://pharmadigest.net/en/articles/2026-09-23-dyrk1a-inhibitor-brain-penetration-alzheimers/https://pharmadigest.net/en/articles/2026-09-23-iambic-therapeutics-nasdaq-ipo-filing/https://pharmadigest.net/en/articles/2026-09-23-lexeo-mantle-friedreich-ataxia-acquisition/https://pharmadigest.net/en/articles/2026-09-23-merck-winrevair-fda-label-hyperion/https://pharmadigest.net/en/articles/2026-09-23-multiparadigm-docking-benchmark-cofolding/https://pharmadigest.net/en/articles/2026-09-23-pancreatic-alpha-amylase-inhibitor-diabetes/https://pharmadigest.net/en/articles/2026-09-23-telix-itm-radiopharma-acquisition/https://pharmadigest.net/en/articles/2026-09-23-ultralarge-virtual-screening-perspective/https://pharmadigest.net/en/articles/2026-09-24-bace1-fragment-growing-cysteine-sulfoxide/https://pharmadigest.net/en/articles/2026-09-24-bayesian-flow-networks-molecular-design/https://pharmadigest.net/en/articles/2026-09-24-celldex-barzolvolimab-phase3-embarq-csu/https://pharmadigest.net/en/articles/2026-09-24-crbn-ptp1b-tcptp-degrader/https://pharmadigest.net/en/articles/2026-09-24-flagship-pioneering-pentagon-biodefense-contract/https://pharmadigest.net/en/articles/2026-09-24-fragment-optimization-smiles-strategies/https://pharmadigest.net/en/articles/2026-09-24-gsk-hansoh-adc-china-strategy/https://pharmadigest.net/en/articles/2026-09-24-incb127443-cdk2-inhibitor/https://pharmadigest.net/en/articles/2026-09-24-novo-medicare-glp1-bridge-terms/https://pharmadigest.net/en/articles/2026-09-24-shp2-orthosteric-to-allosteric-azaindole/https://pharmadigest.net/en/articles/2026-09-24-triazole-stapled-opioid-npff-agonists/https://pharmadigest.net/en/articles/2026-09-24-trmd-antibacterial-target-review/https://pharmadigest.net/en/articles/2026-09-24-trpm7-inhibitors-breast-cancer/https://pharmadigest.net/en/articles/2026-09-27-basecamp-research-series-c-ai-biology-models/https://pharmadigest.net/en/articles/2026-09-27-brain-penetrant-covalent-bche-inhibitor/https://pharmadigest.net/en/articles/2026-09-27-dual-parp-gpx4-inhibitors-tnbc/https://pharmadigest.net/en/articles/2026-09-27-enveda-series-e-ai-natural-medicines/https://pharmadigest.net/en/articles/2026-09-27-exel-1855-plk4-lead-optimization/https://pharmadigest.net/en/articles/2026-09-27-generative-ai-stat3-inhibitor-colorectal-cancer/https://pharmadigest.net/en/articles/2026-09-27-lilly-innocare-china-discovery-collaboration/https://pharmadigest.net/en/articles/2026-09-27-lilly-onswik-weekly-insulin-fda-approval/https://pharmadigest.net/en/articles/2026-09-27-nano-protac-fluorinated-lipid-trafficking/https://pharmadigest.net/en/articles/2026-09-27-novo-nordisk-nanexa-drug-delivery-license/https://pharmadigest.net/en/articles/2026-09-27-phage-qbeta-glycoconjugate-cancer-vaccine/https://pharmadigest.net/en/articles/2026-09-27-roche-xofluza-generic-pandemic-licensing/https://pharmadigest.net/en/articles/2026-09-27-sirna-antibody-oligonucleotide-conjugate-design/https://pharmadigest.net/en/articles/2026-09-27-stat6-protac-atopic-dermatitis/https://pharmadigest.net/en/articles/2026-09-28-amgen-dazodalibep-phase3-sjogrens/https://pharmadigest.net/en/articles/2026-09-28-cell-penetrating-poly-disulfides/https://pharmadigest.net/en/articles/2026-09-28-covalent-encoded-library-peptide-macrocycles/https://pharmadigest.net/en/articles/2026-09-28-fluorinated-isoxazolidinone-apoptosis-inducers/https://pharmadigest.net/en/articles/2026-09-28-imidazolium-bioisostere-methylated-residues/https://pharmadigest.net/en/articles/2026-09-28-newamsterdam-menarini-obicetrapib-eu-approval/https://pharmadigest.net/en/articles/2026-09-28-p53-y220c-nanobret-ligand-validation/https://pharmadigest.net/en/articles/2026-09-28-roche-enicepatide-phase2-diabetes/https://pharmadigest.net/en/articles/2026-09-28-roche-sefaxersen-phase3-igan/https://pharmadigest.net/en/articles/2026-09-28-vertex-inaxaplin-phase2b-kidney/https://pharmadigest.net/en/articles/2026-09-29-abbvie-tavapadon-parkinsons-approval/https://pharmadigest.net/en/articles/2026-09-29-automated-ligand-nmr-hit-triage/https://pharmadigest.net/en/articles/2026-09-29-cruzain-cathepsin-l-covalent-fep/https://pharmadigest.net/en/articles/2026-09-29-csf-penetrant-ttr-stabilizers/https://pharmadigest.net/en/articles/2026-09-29-direct-to-biology-drug-discovery-platform/https://pharmadigest.net/en/articles/2026-09-29-kodiak-daybreak-phase3-wamd/https://pharmadigest.net/en/articles/2026-09-29-lsd1-nucleoside-analogue-response/https://pharmadigest.net/en/articles/2026-09-29-maruho-bms-sotyktu-japan-partnership/https://pharmadigest.net/en/articles/2026-09-29-merck-daiichi-ifinatamab-withdrawal/https://pharmadigest.net/en/articles/2026-09-29-merck-scibrunch-kras-g12d-license/https://pharmadigest.net/en/articles/2026-09-29-mirum-atebrioz-fop-fda-approval/https://pharmadigest.net/en/articles/2026-09-29-murb-pet-imaging-bacterial-infection/https://pharmadigest.net/en/articles/2026-09-30-amatoxin-adc-dhile-payload-sar/https://pharmadigest.net/en/articles/2026-09-30-avb6-albumin-binder-radiotheranostic-tracers/https://pharmadigest.net/en/articles/2026-09-30-genentech-earendil-ai-bispecific-collaboration/https://pharmadigest.net/en/articles/2026-09-30-melittin-wikrk-repeat-beta-sheet-peptides/https://pharmadigest.net/en/articles/2026-09-30-mirum-brelovitug-hepatitis-delta-phase3/https://pharmadigest.net/en/articles/2026-09-30-ptm-binding-free-energy-plac-dataset/https://pharmadigest.net/en/articles/2026-09-30-siderophore-carbapenem-mbl-inhibitor-conjugates/https://pharmadigest.net/en/articles/2026-09-30-tolerance-tanabe-il33-antibody-license/https://pharmadigest.net/en/articles/2026-10-01-astrazeneca-summit-ivonescimab-adc-investment/https://pharmadigest.net/en/articles/2026-10-01-azaphilone-lysine-covalent-probe-bacteria/https://pharmadigest.net/en/articles/2026-10-01-ca-ix-aryl-sulfamate-sar/https://pharmadigest.net/en/articles/2026-10-01-cereblon-protac-prodrug-synthesis/https://pharmadigest.net/en/articles/2026-10-01-dna-glycosylase-hts-inhibitor-dataset/https://pharmadigest.net/en/articles/2026-10-01-gba2-covalent-cyclitol-aziridine-inhibitors/https://pharmadigest.net/en/articles/2026-10-01-merck-recarbrio-us-withdrawal/https://pharmadigest.net/en/articles/2026-10-01-novo-hengrui-oral-glp1-gip-license/https://pharmadigest.net/en/articles/2026-10-01-roche-emugrobart-obesity-discontinued/https://pharmadigest.net/en/articles/2026-10-01-rxfp4-gut-restricted-agonists-constipation/https://pharmadigest.net/en/articles/2026-10-02-bmtacs-bbb-macrocyclic-dapk1-degraders/https://pharmadigest.net/en/articles/2026-10-02-boltz2-cofolding-akr1b10-virtual-screening/https://pharmadigest.net/en/articles/2026-10-02-dt-9081-ep4-antagonist-scaffold-hopping/https://pharmadigest.net/en/articles/2026-10-02-grp78-isoform-selective-direct-to-biology/https://pharmadigest.net/en/articles/2026-10-02-hdac8-compact-two-in-one-protac/https://pharmadigest.net/en/articles/2026-10-02-lilly-eloratzp-amylin-tirzepatide-phase2b/https://pharmadigest.net/en/articles/2026-10-02-native-ms-protac-ternary-linker-ligand-brd4/https://pharmadigest.net/en/articles/2026-10-02-nav17-quinazoline-microed-neuropathic-pain/https://pharmadigest.net/en/articles/2026-10-02-p300-cbp-inhibitors-vs-bifunctional-modalities/https://pharmadigest.net/en/articles/2026-10-02-sanofi-regeneron-alliance-expansion-four-antibodies/https://pharmadigest.net/en/articles/2026-10-03-covalent-map2k4-7-pdac/https://pharmadigest.net/en/articles/2026-10-03-hiv-nnrti-jk4b-entrance-channel/https://pharmadigest.net/en/articles/2026-10-03-induced-proximity-o-glcnacylation/https://pharmadigest.net/en/articles/2026-10-03-kit-selective-class-iii-rtk/https://pharmadigest.net/en/articles/2026-10-03-novartis-abogen-mrna-tce/https://pharmadigest.net/en/articles/2026-10-03-oral-glp1-small-molecule-agonists-review/https://pharmadigest.net/en/articles/2026-10-03-scope-concept-hit-finding/https://pharmadigest.net/en/articles/2026-10-03-tce-coiled-coil-protease-activation/https://pharmadigest.net/en/articles/2026-10-04-boehringer-zealand-survodutide-phase3-tolerability/https://pharmadigest.net/en/articles/2026-10-04-despot-anisotropic-scoring-potentials/https://pharmadigest.net/en/articles/2026-10-04-gtac-gpcr-antagonism-receptor-degradation/https://pharmadigest.net/en/articles/2026-10-04-lb10-cd73-inhibitor-lung-cancer/https://pharmadigest.net/en/articles/2026-10-04-novo-orbis-oral-macrocycle-cardiometabolic-deal/https://pharmadigest.net/en/articles/2026-10-04-protac-linker-analogue-scoring-vhl-shp2/https://pharmadigest.net/en/articles/2026-10-04-soft-drugs-design-principles-topical/https://pharmadigest.net/en/articles/2026-10-05-click-triggered-cope-elimination-michael-acceptor-activation/https://pharmadigest.net/en/articles/2026-10-05-dna-origami-barnase-rna-degrader-mutant-kras-mrna/https://pharmadigest.net/en/articles/2026-10-05-gspt1-glue-lgne29-glioblastoma/https://pharmadigest.net/en/articles/2026-10-05-jcr-italfarmaco-izcargo-jr-141-license/https://pharmadigest.net/en/articles/2026-10-05-kpb82-acer2-inhibitor-doxorubicin-protection/https://pharmadigest.net/en/articles/2026-10-05-pappa-phosphinate-phosphonate-inhibitors-igf-signaling/https://pharmadigest.net/en/articles/2026-10-05-summit-astrazeneca-daiichi-ivonescimab-datroway-tnbc-collaboration/https://pharmadigest.net/en/articles/2026-10-06-csl-alentis-lixudebart-claudin-1-partnership/https://pharmadigest.net/en/articles/2026-10-06-fto-inhibitors-pyridazine-nicotinamide-aml/https://pharmadigest.net/en/articles/2026-10-06-genmab-rina-s-ovarian-phase2-vs-elahere/https://pharmadigest.net/en/articles/2026-10-06-lilly-jaypirca-first-line-cll-approval/https://pharmadigest.net/en/articles/2026-10-06-nsd2-gspt1-single-atom-degrader-selectivity/https://pharmadigest.net/en/articles/2026-10-06-pan-ythdf-ligands-structure-based-design/https://pharmadigest.net/en/articles/2026-10-06-photoactivatable-vegfr2-inhibitors-retina/https://pharmadigest.net/en/articles/2026-10-06-shionogi-intrabio-acquisition-aqneursa/https://pharmadigest.net/en/articles/2026-10-07-egfr-protac-hqy1480-macrocyclic-bi4020/https://pharmadigest.net/en/articles/2026-10-07-genentech-alector-al050-gcase-parkinsons-license/https://pharmadigest.net/en/articles/2026-10-07-hipk4-cyanoquinoline-inhibitors-male-contraception/https://pharmadigest.net/en/articles/2026-10-07-lycia-lytac-extracellular-degrader-ipo-filing/https://pharmadigest.net/en/articles/2026-10-07-merck-scibrunch-kras-g12d-spr2015-license/https://pharmadigest.net/en/articles/2026-10-07-nlrp3-thienopyrimidinone-istradefylline-colitis/https://pharmadigest.net/en/articles/2026-10-07-ogg1-organocatalytic-switches-mitochondria-neuroprotection/https://pharmadigest.net/en/articles/2026-10-07-pkmyt1-4-aminoquinazoline-ccne1-donor-acceptor/https://pharmadigest.net/en/articles/2026-10-08-astrazeneca-kendall-square-boston-rd-site/https://pharmadigest.net/en/articles/2026-10-08-caribou-biosciences-wind-down-car-t/https://pharmadigest.net/en/articles/2026-10-08-chiral-imidazoquinoline-tlr7-8-agonist-antagonist/https://pharmadigest.net/en/articles/2026-10-08-dengue-ns4b-structure-guided-inhibitor-3dqsar/https://pharmadigest.net/en/articles/2026-10-08-lanosterol-derivative-bbb-abeta-aggregation-alzheimers/https://pharmadigest.net/en/articles/2026-10-08-pkmyt1-carboxamide-inhibitors-patent-overview/https://pharmadigest.net/en/articles/2026-10-09-docking-accuracy-vs-number-of-crystal-structures/https://pharmadigest.net/en/articles/2026-10-09-forbion-raises-2-6-billion-fund/https://pharmadigest.net/en/articles/2026-10-09-frespaciguat-mk-5475-inhaled-sgc-stimulator/https://pharmadigest.net/en/articles/2026-10-09-merck-keytruda-subcutaneous-dutch-court-halt/https://pharmadigest.net/en/articles/2026-10-09-perk-inhibitor-apl-11056-clinical-candidate/https://pharmadigest.net/en/articles/2026-10-09-polq-polymerase-inhibitors-benzimidazoles-purines/https://pharmadigest.net/en/articles/2026-10-09-roche-defand-molecular-glue-discovery-deal/https://pharmadigest.net/en/articles/2026-10-09-sulfonium-echinocandins-cryptococcus/https://pharmadigest.net/en/articles/2026-10-09-ulk1-selective-protac-kras-mutant-cancer/https://pharmadigest.net/en/articles/2026-10-10-argenx-vyvgart-sjogrens-phase3-failure/https://pharmadigest.net/en/articles/2026-10-10-arrivent-furvent-phase3-firmonertinib-miss/https://pharmadigest.net/en/articles/2026-10-10-brain-penetrant-colchicine-site-ligand-glioma/https://pharmadigest.net/en/articles/2026-10-10-dnmt1-protac-b7-liver-fibrosis/https://pharmadigest.net/en/articles/2026-10-10-enpp1-boronic-acid-inhibitors-ph-resilient/https://pharmadigest.net/en/articles/2026-10-10-fragdockrl-reinforcement-learning-fragment-design/https://pharmadigest.net/en/articles/2026-10-10-hdac2-selective-inhibitor-ktt-1-kinetics/https://pharmadigest.net/en/articles/2026-10-10-hsp90b-chimeric-selective-inhibitors/https://pharmadigest.net/en/articles/2026-10-10-maglistat-del-hit-magli-432-five-star-matrix/https://pharmadigest.net/en/articles/2026-10-10-qpct-l-inhibitors-virtual-screening-bi-3614/https://pharmadigest.net/en/articles/2026-10-12-donepezil-based-dual-buche-faah-inhibitors/https://pharmadigest.net/en/articles/2026-10-12-flexenn-gnn-binding-energy-disordered-proteins/https://pharmadigest.net/en/articles/2026-10-12-lactam-bridged-peptide-il-11-antagonist/https://pharmadigest.net/en/articles/2026-10-12-lasb-hydroxamate-inhibitors-ktgs/https://pharmadigest.net/en/articles/2026-10-12-life-biosciences-glaucoma-reprogramming-update/https://pharmadigest.net/en/articles/2026-10-12-lrrk2-g2019s-selective-indazole-bicyclic/https://pharmadigest.net/en/articles/2026-10-12-masked-bisphosphonate-acid-sphingomyelinase-inhibitors/https://pharmadigest.net/en/articles/2026-10-12-siderophore-ampicillin-conjugate-pseudomonas/https://pharmadigest.net/en/articles/2026-10-12-viatris-pacira-non-opioid-pain-acquisition/https://pharmadigest.net/en/articles/2026-10-13-ferulic-acid-protac-tlr4-degradation-endothelium/https://pharmadigest.net/en/articles/2026-10-13-gpr183-g-protein-biased-agonist-tug-2604/https://pharmadigest.net/en/articles/2026-10-13-kdm6b-diaryl-pyrimidine-guanidine-cervical-cancer/https://pharmadigest.net/en/articles/2026-10-13-mor-d3r-dual-target-ligands-ls01-64-opioid/https://pharmadigest.net/en/articles/2026-10-13-stk33-inhibitors-cdd-3094-male-contraception/https://pharmadigest.net/en/articles/2026-10-13-vhl-hdac6-protacs-solid-phase-linker-sar/https://pharmadigest.net/en/articles/2026-10-14-benzothiophene-mprb-antivirulence-tuberculosis/https://pharmadigest.net/en/articles/2026-10-14-dcl1191-tfeb-inhibitor-from-eltrombopag/https://pharmadigest.net/en/articles/2026-10-14-hdac6-l2-pocket-inhibitors-lung-cancer/https://pharmadigest.net/en/articles/2026-10-14-neurocrine-vykat-xr-prader-willi-safety-concerns/https://pharmadigest.net/en/articles/2026-10-14-pdia3-n-hydroxyindole-carboxamide-antivirals/https://pharmadigest.net/en/articles/2026-10-14-peptide-like-del-403200-compounds-diversity/https://pharmadigest.net/en/articles/2026-10-14-pi4kiiib-hdac-dual-inhibitors-hcv/https://pharmadigest.net/en/articles/2026-10-14-sting-inhibitor-d4-severe-acute-pancreatitis/https://pharmadigest.net/en/articles/2026-10-14-tubulin-hdac8-dual-inhibitor-millepachine-ovarian/https://pharmadigest.net/en/articles/2026-10-15-chd4-macrocycle-nurd-interaction-hub/https://pharmadigest.net/en/articles/2026-10-15-cinchona-ammonium-long-acting-nerve-block/https://pharmadigest.net/en/articles/2026-10-15-covalent-fragment-lysine-shp2-latch-site/https://pharmadigest.net/en/articles/2026-10-15-del-ml-docking-cofolding-generalizability/https://pharmadigest.net/en/articles/2026-10-15-gtp-state-kras-g12c-covalent-keto-indolizine/https://pharmadigest.net/en/articles/2026-10-15-lrrk2-g2019s-selective-octahydrocyclopentapyrrole/https://pharmadigest.net/en/articles/2026-10-15-oral-stat6-degrader-ww-210-atopic-dermatitis/https://pharmadigest.net/en/articles/2026-10-15-sanofi-eu-antitrust-flu-vaccine-commitments/https://pharmadigest.net/en/articles/2026-10-16-anti-apoptotic-bax-inhibitors-egfr-scaffold/https://pharmadigest.net/en/articles/2026-10-16-bcl6-protac-oxazinoquinolinone-dlbcl/https://pharmadigest.net/en/articles/2026-10-16-cysteine-reactive-early-mitotic-inhibitors/https://pharmadigest.net/en/articles/2026-10-16-elevenostat-not-hdac11-selective-probe/https://pharmadigest.net/en/articles/2026-10-16-gilead-vir-dual-masked-t-cell-engagers/https://pharmadigest.net/en/articles/2026-10-16-gta182-mta-cooperative-prmt5-cns/https://pharmadigest.net/en/articles/2026-10-16-nav17-aminopyrimidine-state-independent-probe/https://pharmadigest.net/en/articles/2026-10-16-pfizer-enodia-sec61-inhibitors/https://pharmadigest.net/en/articles/2026-10-16-roche-rona-alk7-rnai-obesity/https://pharmadigest.net/en/articles/2026-10-16-slc6a19-allosteric-inhibitors-oral/https://pharmadigest.net/en/articles/2026-10-16-tau-lrp1-hts-small-molecule-inhibitors/https://pharmadigest.net/en/articles/2026-10-16-verastem-vs-7375-kras-g12d-pancreatic/https://pharmadigest.net/en/articles/2026-10-16-zealand-generate-multispecific-obesity/https://pharmadigest.net/en/articles/2026-10-17-astrazeneca-insitro-ai-target-discovery-deal/https://pharmadigest.net/en/articles/2026-10-17-brain-penetrant-egfr-tki-crystal-structures/https://pharmadigest.net/en/articles/2026-10-17-cereblon-cys287-allosteric-covalent-inhibitor/https://pharmadigest.net/en/articles/2026-10-17-hdac11-yp200-indole-hydroxamate-nsclc/https://pharmadigest.net/en/articles/2026-10-17-merck-moderna-mrna-cancer-vaccine-keytruda-strategy/https://pharmadigest.net/en/articles/2026-10-17-mrgprx2-pyrazolopyrimidine-incb187175/https://pharmadigest.net/en/articles/2026-10-17-revmed-rasonque-eu-approval-recommendation/https://pharmadigest.net/en/articles/2026-10-17-rhoj-n-terminal-pocket-terconazole/https://pharmadigest.net/en/articles/2026-10-17-rpt04402-pp2a-molecular-glue-uterine-cancer/https://pharmadigest.net/en/articles/2026-10-17-ttbk1-2-5-azaindole-probe-ciliogenesis/https://pharmadigest.net/en/articles/2026-10-17-vg-3927-oral-trem2-agonist-alzheimers/https://pharmadigest.net/en/articles/2026-10-18-benzodiazepine-antimalarial-pfset3-g9a/https://pharmadigest.net/en/articles/2026-10-18-bptf-phd-bromodomain-bivalent-inhibitor/https://pharmadigest.net/en/articles/2026-10-18-lakefront-armed-cell-car-t-programs-sale/https://pharmadigest.net/en/articles/2026-10-18-myc-de-novo-protein-binders-tumor-growth/https://pharmadigest.net/en/articles/2026-10-18-pd-qsar-quantile-potency-extrapolation/https://pharmadigest.net/en/articles/2026-10-18-rab27a-macrocyclic-peptide-effector-free-crystal/https://pharmadigest.net/en/articles/2026-10-19-charmm-gui-covalent-ligand-docker-autodock4/https://pharmadigest.net/en/articles/2026-10-19-chemophototherapy-repurposed-anthracenediones-photosensitizers/https://pharmadigest.net/en/articles/2026-10-19-hsa-fe4-ferric-agent-triple-negative-breast-cancer/https://pharmadigest.net/en/articles/2026-10-19-lilly-gate-bioscience-sec61-collaboration-expansion/https://pharmadigest.net/en/articles/2026-10-20-epoxysuccinate-covalent-sars-cov-2-plpro-inhibitors/https://pharmadigest.net/en/articles/2026-10-20-gilead-emvistegrast-swift-phase2-ulcerative-colitis/https://pharmadigest.net/en/articles/2026-10-20-isg15-uba7-alphalisa-high-throughput-screen/https://pharmadigest.net/en/articles/2026-10-20-kinase-inhibitor-protonation-tautomer-shifts-mcce/https://pharmadigest.net/en/articles/2026-10-20-merck-kgaa-silence-therapeutics-acquisition/https://pharmadigest.net/en/articles/2026-10-20-parp1-selective-cns-penetrant-triazolopyridinyl-piperazine/https://pharmadigest.net/en/articles/2026-10-20-protac-unbound-exposure-e3-target-engagement/https://pharmadigest.net/en/articles/2026-10-21-cenpb-oligotac-dna-protac-nsclc/https://pharmadigest.net/en/articles/2026-10-21-china-draft-curbs-foreign-biopharma-acquisitions/https://pharmadigest.net/en/articles/2026-10-21-dcn1-ube2m-inhibitor-herg-reduction/https://pharmadigest.net/en/articles/2026-10-21-fgfr3-selective-inhibitors-perspective/https://pharmadigest.net/en/articles/2026-10-21-iwy357-pyrazine-carboxamide-antimalarial/https://pharmadigest.net/en/articles/2026-10-21-sf-ga-pgp-substrate-to-nonsubstrate-redesign/https://pharmadigest.net/en/articles/2026-10-22-cofolding-models-ligand-placement-vs-protein-conformation/https://pharmadigest.net/en/articles/2026-10-22-gsk-fda-approval-hepatitis-b-functional-cure/https://pharmadigest.net/en/articles/2026-10-22-inhaled-ddr-inhibitors-pyrrolopyrimidine-ipf/https://pharmadigest.net/en/articles/2026-10-22-macrocyclic-cdk7-pyrazolotriazine-oral-selective/https://pharmadigest.net/en/articles/2026-10-22-mkk3-non-atp-competitive-modulators-ulcerative-colitis/https://pharmadigest.net/en/articles/2026-10-22-roche-hansoh-adc-portfolio-collaboration/https://pharmadigest.net/en/articles/2026-10-22-roivant-positive-trial-non-infectious-uveitis/https://pharmadigest.net/en/articles/2026-10-22-ttk-monovalent-degrader-monomethyl-fumarate-rnf126/https://pharmadigest.net/en/articles/2026-10-22-ube2d2-electrophile-first-covalent-aminothiazole/https://pharmadigest.net/en/articles/2026-10-22-yks-34-pde4b-selective-ipf/https://pharmadigest.net/en/articles/2026-10-23-aimnet2-cpcm-ligand-strain-solvated/https://pharmadigest.net/en/articles/2026-10-23-bcl9-beta-catenin-inhibitor-glioma/https://pharmadigest.net/en/articles/2026-10-23-brd9-protac-mouse-crbn-vhl-species-gap/https://pharmadigest.net/en/articles/2026-10-23-isomorphic-labs-valuation-ai-drug-discovery/https://pharmadigest.net/en/articles/2026-10-23-lilly-metis-ai-lnp-delivery-deal/https://pharmadigest.net/en/articles/2026-10-23-pyrroloquinoline-antitubulin-drug-resistant/https://pharmadigest.net/en/articles/2026-10-23-sting-inhibitor-tetrahydropyrazolopyrazine-oral/https://pharmadigest.net/en/articles/2026-10-23-tlr7-tlr8-pyridone-indole-antagonists-brd4-offtarget/https://pharmadigest.net/en/computational/https://pharmadigest.net/en/computational/archive/https://pharmadigest.net/en/computational/archive/2026/09/https://pharmadigest.net/en/computational/archive/2026/10/https://pharmadigest.net/en/digest/2026-08-31/https://pharmadigest.net/en/digest/2026-09-01/https://pharmadigest.net/en/digest/2026-09-02/https://pharmadigest.net/en/digest/2026-09-03/https://pharmadigest.net/en/digest/2026-09-11/https://pharmadigest.net/en/digest/2026-09-12/https://pharmadigest.net/en/digest/2026-09-13/https://pharmadigest.net/en/digest/2026-09-14/https://pharmadigest.net/en/digest/2026-09-15/https://pharmadigest.net/en/digest/2026-09-16/https://pharmadigest.net/en/digest/2026-09-17/https://pharmadigest.net/en/digest/2026-09-18/https://pharmadigest.net/en/digest/2026-09-19/https://pharmadigest.net/en/digest/2026-09-21/https://pharmadigest.net/en/digest/2026-09-22/https://pharmadigest.net/en/digest/2026-09-23/https://pharmadigest.net/en/digest/2026-09-24/https://pharmadigest.net/en/digest/2026-09-27/https://pharmadigest.net/en/digest/2026-09-28/https://pharmadigest.net/en/digest/2026-09-29/https://pharmadigest.net/en/digest/2026-09-30/https://pharmadigest.net/en/digest/2026-10-01/https://pharmadigest.net/en/digest/2026-10-02/https://pharmadigest.net/en/digest/2026-10-03/https://pharmadigest.net/en/digest/2026-10-04/https://pharmadigest.net/en/digest/2026-10-05/https://pharmadigest.net/en/digest/2026-10-06/https://pharmadigest.net/en/digest/2026-10-07/https://pharmadigest.net/en/digest/2026-10-08/https://pharmadigest.net/en/digest/2026-10-09/https://pharmadigest.net/en/digest/2026-10-10/https://pharmadigest.net/en/digest/2026-10-12/https://pharmadigest.net/en/digest/2026-10-13/https://pharmadigest.net/en/digest/2026-10-14/https://pharmadigest.net/en/digest/2026-10-15/https://pharmadigest.net/en/digest/2026-10-16/https://pharmadigest.net/en/digest/2026-10-17/https://pharmadigest.net/en/digest/2026-10-18/https://pharmadigest.net/en/digest/2026-10-19/https://pharmadigest.net/en/digest/2026-10-20/https://pharmadigest.net/en/digest/2026-10-21/https://pharmadigest.net/en/digest/2026-10-22/https://pharmadigest.net/en/digest/2026-10-23/https://pharmadigest.net/en/disclaimer/https://pharmadigest.net/en/industry/https://pharmadigest.net/en/industry/archive/https://pharmadigest.net/en/industry/archive/2026/08/https://pharmadigest.net/en/industry/archive/2026/09/https://pharmadigest.net/en/industry/archive/2026/10/https://pharmadigest.net/en/medchem/https://pharmadigest.net/en/medchem/archive/https://pharmadigest.net/en/medchem/archive/2026/09/https://pharmadigest.net/en/medchem/archive/2026/10/https://pharmadigest.net/en/pharmacology/https://pharmadigest.net/en/pharmacology/archive/https://pharmadigest.net/en/pharmacology/archive/2026/09/https://pharmadigest.net/en/pharmacology/archive/2026/10/https://pharmadigest.net/en/privacy/https://pharmadigest.net/en/search/https://pharmadigest.net/en/sources/https://pharmadigest.net/en/terms/https://pharmadigest.net/en/topics/https://pharmadigest.net/en/topics/adc/https://pharmadigest.net/en/topics/ai-ml/https://pharmadigest.net/en/topics/antibodies/https://pharmadigest.net/en/topics/cardiovascular/https://pharmadigest.net/en/topics/cell-gene-therapy/https://pharmadigest.net/en/topics/chemical-biology/https://pharmadigest.net/en/topics/china-biotech/https://pharmadigest.net/en/topics/clinical-readouts/https://pharmadigest.net/en/topics/clinical-readouts/2/https://pharmadigest.net/en/topics/covalent/https://pharmadigest.net/en/topics/del/https://pharmadigest.net/en/topics/dmpk/https://pharmadigest.net/en/topics/drug-repurposing/https://pharmadigest.net/en/topics/epigenetics/https://pharmadigest.net/en/topics/fbdd/https://pharmadigest.net/en/topics/financing/https://pharmadigest.net/en/topics/gpcrs/https://pharmadigest.net/en/topics/hit-finding/https://pharmadigest.net/en/topics/immune-checkpoints/https://pharmadigest.net/en/topics/immunology/https://pharmadigest.net/en/topics/immunology/2/https://pharmadigest.net/en/topics/infectious-disease/https://pharmadigest.net/en/topics/infectious-disease/2/https://pharmadigest.net/en/topics/kinases/https://pharmadigest.net/en/topics/kinases/2/https://pharmadigest.net/en/topics/lead-optimization/https://pharmadigest.net/en/topics/lead-optimization/2/https://pharmadigest.net/en/topics/lead-optimization/3/https://pharmadigest.net/en/topics/licensing-partnerships/https://pharmadigest.net/en/topics/licensing-partnerships/2/https://pharmadigest.net/en/topics/m-and-a/https://pharmadigest.net/en/topics/metabolic/https://pharmadigest.net/en/topics/molecular-simulation/https://pharmadigest.net/en/topics/neuroscience/https://pharmadigest.net/en/topics/neuroscience/2/https://pharmadigest.net/en/topics/oligonucleotides/https://pharmadigest.net/en/topics/oncology/https://pharmadigest.net/en/topics/oncology/2/https://pharmadigest.net/en/topics/oncology/3/https://pharmadigest.net/en/topics/oncology/4/https://pharmadigest.net/en/topics/peptides/https://pharmadigest.net/en/topics/ppi/https://pharmadigest.net/en/topics/protein-degradation/https://pharmadigest.net/en/topics/protein-degradation/2/https://pharmadigest.net/en/topics/ras/https://pharmadigest.net/en/topics/regulatory/https://pharmadigest.net/en/topics/restructuring/https://pharmadigest.net/en/topics/structure-based-design/https://pharmadigest.net/en/topics/synthesis/https://pharmadigest.net/en/topics/virtual-screening/https://pharmadigest.net/ja/https://pharmadigest.net/ja/archive/https://pharmadigest.net/ja/archive/2026/https://pharmadigest.net/ja/archive/2026/08/https://pharmadigest.net/ja/archive/2026/09/https://pharmadigest.net/ja/archive/2026/10/https://pharmadigest.net/ja/articles/2026-08-31-alnylam-astrazeneca-wainua-attr-cm-trial-failure/https://pharmadigest.net/ja/articles/2026-08-31-genentech-dualitybio-adc-payload-deal/https://pharmadigest.net/ja/articles/2026-09-01-novartis-bms-autoimmune-car-t-trial-pause/https://pharmadigest.net/ja/articles/2026-09-02-alumis-envudeucitinib-lupus-trial-miss/https://pharmadigest.net/ja/articles/2026-09-02-eli-lilly-merida-biosciences-acquisition/https://pharmadigest.net/ja/articles/2026-09-02-novartis-remibrutinib-multiple-sclerosis-phase3/https://pharmadigest.net/ja/articles/2026-09-02-uniqure-amt130-huntingtons-bla-submission/https://pharmadigest.net/ja/articles/2026-09-03-arpa-h-rna-manufacturing-give-program-funding/https://pharmadigest.net/ja/articles/2026-09-03-fiz1-molecular-glue-thalidomide-degrader/https://pharmadigest.net/ja/articles/2026-09-03-gsk-mrna-flu-vaccine-phase3-dual-ha-na/https://pharmadigest.net/ja/articles/2026-09-03-roche-simcere-zaiming-sim0660-trispecific-license/https://pharmadigest.net/ja/articles/2026-09-03-tscan-therapeutics-workforce-cut-solid-tumor-pivot/https://pharmadigest.net/ja/articles/2026-09-03-ultragenyx-angelman-apazunersen-phase3-failure/https://pharmadigest.net/ja/articles/2026-09-11-aerobactin-aztreonam-siderophore-conjugate/https://pharmadigest.net/ja/articles/2026-09-11-astrazeneca-tozorakimab-copd-phase3/https://pharmadigest.net/ja/articles/2026-09-11-bayer-hyrnuo-fda-approval-expansion/https://pharmadigest.net/ja/articles/2026-09-11-ctmd-metadynamics-hit-triage/https://pharmadigest.net/ja/articles/2026-09-11-dt-9081-ep4-receptor-antagonist/https://pharmadigest.net/ja/articles/2026-09-11-elix-axcelead-tpd-partnership/https://pharmadigest.net/ja/articles/2026-09-11-g-quadruplex-parp1-transcriptional-silencer/https://pharmadigest.net/ja/articles/2026-09-11-grp78-isoform-selective-inhibitor-d2b/https://pharmadigest.net/ja/articles/2026-09-11-hdac8-protac-compact-2in1-degrader/https://pharmadigest.net/ja/articles/2026-09-11-kura-oncology-caspian-therapeutics-spinoff/https://pharmadigest.net/ja/articles/2026-09-11-novartis-del-desiran-dm1-phase3-failure/https://pharmadigest.net/ja/articles/2026-09-11-novartis-pelacarsen-lpa-horizon-failure/https://pharmadigest.net/ja/articles/2026-09-11-novo-nordisk-ziltivekimab-trials-halted/https://pharmadigest.net/ja/articles/2026-09-11-p53-mutant-covalent-stabilizer-rvjb59/https://pharmadigest.net/ja/articles/2026-09-11-phopex-binding-to-release-conjugate-chemistry/https://pharmadigest.net/ja/articles/2026-09-11-schrodinger-tectora-immunology-license/https://pharmadigest.net/ja/articles/2026-09-11-siglec-7-bicyclic-peptide-inhibitors/https://pharmadigest.net/ja/articles/2026-09-11-tri-611-alk-molecular-glue-degrader/https://pharmadigest.net/ja/articles/2026-09-11-twostep-therapeutics-series-a-ts-104/https://pharmadigest.net/ja/articles/2026-09-11-virtual-screening-benchmark-resolution-limits/https://pharmadigest.net/ja/articles/2026-09-12-astrazeneca-etcamah-ctdna-guided-approval/https://pharmadigest.net/ja/articles/2026-09-12-biomarin-voxzogo-hypochondroplasia-phase3/https://pharmadigest.net/ja/articles/2026-09-12-cd38-cns-penetrant-tricyclic-inhibitors/https://pharmadigest.net/ja/articles/2026-09-12-evommune-evo756-atopic-dermatitis-failure/https://pharmadigest.net/ja/articles/2026-09-12-kalirin-rac1-molecular-glue-inhibitor/https://pharmadigest.net/ja/articles/2026-09-12-mapvis-antibiotic-virtual-screening/https://pharmadigest.net/ja/articles/2026-09-12-tideglusib-nata-chemical-probe/https://pharmadigest.net/ja/articles/2026-09-13-astrazeneca-camizestrant-serena-4-trial-miss/https://pharmadigest.net/ja/articles/2026-09-13-b3gat3-first-in-class-hepatocellular-carcinoma-inhibitors/https://pharmadigest.net/ja/articles/2026-09-13-hiv-1-nnrti-entrance-channel-optimization/https://pharmadigest.net/ja/articles/2026-09-13-oral-glp-1-small-molecule-blueprint/https://pharmadigest.net/ja/articles/2026-09-13-pfama1-cryptic-loop-antimalarial-design/https://pharmadigest.net/ja/articles/2026-09-13-scholar-rock-apitegromab-sma-fda-approval/https://pharmadigest.net/ja/articles/2026-09-13-shionogi-cefiderocol-australia-approval/https://pharmadigest.net/ja/articles/2026-09-13-sufex-dna-encoded-macrocyclic-peptide-libraries/https://pharmadigest.net/ja/articles/2026-09-13-vav1-molecular-glue-ai-protein-folding/https://pharmadigest.net/ja/articles/2026-09-14-akr1b10-inhibitors-boltz2-cofolding/https://pharmadigest.net/ja/articles/2026-09-14-homocamptothecin-adc-payload/https://pharmadigest.net/ja/articles/2026-09-14-solstice-oncology-harbour-biomed-ctla4-licensing/https://pharmadigest.net/ja/articles/2026-09-15-biohaven-sk-biopharmaceuticals-opakalim-clinical-hold/https://pharmadigest.net/ja/articles/2026-09-15-bioxcel-teva-bankruptcy-asset-sale/https://pharmadigest.net/ja/articles/2026-09-15-definium-lsd-anxiety-phase3-fda-filing/https://pharmadigest.net/ja/articles/2026-09-15-hts-mcu-activator-cardiac-bioenergetics/https://pharmadigest.net/ja/articles/2026-09-16-akeso-summit-ivonescimab-keytruda-survival/https://pharmadigest.net/ja/articles/2026-09-16-biontech-oncoc4-gotistobart-lung-cancer-survival/https://pharmadigest.net/ja/articles/2026-09-16-bridgebio-oncology-kras-bbo8520-narrowing/https://pharmadigest.net/ja/articles/2026-09-16-chemberta-casp4-virtual-screening-alzheimers/https://pharmadigest.net/ja/articles/2026-09-16-crbn-molecular-glue-wbp4-degrader/https://pharmadigest.net/ja/articles/2026-09-16-cyclic-peptide-protacs-hif1a-vhl-degrader/https://pharmadigest.net/ja/articles/2026-09-16-gpr41-endotoxemia-autophagy-target/https://pharmadigest.net/ja/articles/2026-09-16-merck-kgaa-postera-fertility-acquisition/https://pharmadigest.net/ja/articles/2026-09-16-photoactive-parp1-inhibitors-computational-design/https://pharmadigest.net/ja/articles/2026-09-16-reactive-metallo-scaffolds-prmt1-target-id/https://pharmadigest.net/ja/articles/2026-09-16-thrombin-inhibitor-dynamic-combinatorial-chemistry/https://pharmadigest.net/ja/articles/2026-09-16-trim24-bromodomain-nonhistone-interactome/https://pharmadigest.net/ja/articles/2026-09-16-vera-trutakna-igan-origin3-phase3/https://pharmadigest.net/ja/articles/2026-09-17-bmtac-bbb-permeable-tpd-aging-brain/https://pharmadigest.net/ja/articles/2026-09-17-chemberta-ai-screening-casp4-inhibitors/https://pharmadigest.net/ja/articles/2026-09-17-ctlh-mkln1-e3-ligase-degron-recognition/https://pharmadigest.net/ja/articles/2026-09-17-encoded-therapeutics-series-f-dravet-gene-therapy/https://pharmadigest.net/ja/articles/2026-09-17-gsk-chimagen-trispecific-tce-multiple-myeloma/https://pharmadigest.net/ja/articles/2026-09-17-h-phosphonate-oligonucleotide-sar-platform/https://pharmadigest.net/ja/articles/2026-09-17-hces2a-nir-fluorogenic-probe-inhibitor-discovery/https://pharmadigest.net/ja/articles/2026-09-17-merck-rahway-layoffs-pipeline-cuts/https://pharmadigest.net/ja/articles/2026-09-17-pyridine-chemoselective-bioconjugate-platform/https://pharmadigest.net/ja/articles/2026-09-17-usp7-targeted-protein-stabilization-screening/https://pharmadigest.net/ja/articles/2026-09-17-vera-trutakna-iga-nephropathy-phase3/https://pharmadigest.net/ja/articles/2026-09-17-wbp4-crbn-molecular-glue-degrader/https://pharmadigest.net/ja/articles/2026-09-18-astrazeneca-enhertu-nhs-england-nice-pricing-deal/https://pharmadigest.net/ja/articles/2026-09-18-biontech-oncoc4-gotistobart-phase3-nsclc/https://pharmadigest.net/ja/articles/2026-09-18-cmyc-ribotac-linker-optimization/https://pharmadigest.net/ja/articles/2026-09-18-cyp8b1-quinoline-inhibitors-metabolic-disease/https://pharmadigest.net/ja/articles/2026-09-18-flavonoid-bioisosteric-aromatase-inhibitors/https://pharmadigest.net/ja/articles/2026-09-18-hdac4-hdac7-isoform-selective-th17-inhibitors/https://pharmadigest.net/ja/articles/2026-09-18-keap1-nrf2-cofolding-screening-cascade-benchmarks/https://pharmadigest.net/ja/articles/2026-09-18-merck-kgaa-postera-fertility-acquisition/https://pharmadigest.net/ja/articles/2026-09-18-novo-nordisk-ascendis-glp1-deal-termination/https://pharmadigest.net/ja/articles/2026-09-18-p38delta-self-encapsulating-kinase-inhibitor/https://pharmadigest.net/ja/articles/2026-09-18-sellas-regal-trial-aml-expected-failure/https://pharmadigest.net/ja/articles/2026-09-18-sionna-layoffs-cystic-fibrosis-trial-failure/https://pharmadigest.net/ja/articles/2026-09-18-sling-therapeutics-series-c-linsitinib/https://pharmadigest.net/ja/articles/2026-09-18-stellar-fragment-based-peptide-docking/https://pharmadigest.net/ja/articles/2026-09-18-taar1-agonists-structure-based-discovery/https://pharmadigest.net/ja/articles/2026-09-18-thrombin-inhibitor-dynamic-combinatorial-chemistry/https://pharmadigest.net/ja/articles/2026-09-18-trim24-bromodomain-nonhistone-interactome/https://pharmadigest.net/ja/articles/2026-09-19-ariadne-bio-parkinsons-apathy-launch/https://pharmadigest.net/ja/articles/2026-09-19-astrazeneca-enhertu-nice-england-pricing/https://pharmadigest.net/ja/articles/2026-09-19-hdac4-hdac7-selective-inhibitors-th17/https://pharmadigest.net/ja/articles/2026-09-19-hyreptaones-cav31-calcium-channel-inhibitors/https://pharmadigest.net/ja/articles/2026-09-19-jacs-degrader-antibody-conjugate-tumor-stroma/https://pharmadigest.net/ja/articles/2026-09-19-keap1-nrf2-virtual-screening-stress-test/https://pharmadigest.net/ja/articles/2026-09-19-kinase-catalytic-cluster-residues-structural-survey/https://pharmadigest.net/ja/articles/2026-09-19-longeveron-elpis-ii-phase2b-failure/https://pharmadigest.net/ja/articles/2026-09-19-north-immunology-aethlon-reverse-merger/https://pharmadigest.net/ja/articles/2026-09-19-omaveloxolone-sting-degrader-repurposing/https://pharmadigest.net/ja/articles/2026-09-19-scope-chemical-space-hit-finding/https://pharmadigest.net/ja/articles/2026-09-19-sellas-regal-aml-trial-outlook/https://pharmadigest.net/ja/articles/2026-09-19-sling-therapeutics-series-c-thyroid-eye-disease/https://pharmadigest.net/ja/articles/2026-09-19-ultragenyx-fayuvi-sanfilippo-approval/https://pharmadigest.net/ja/articles/2026-09-21-bms-orum-orm6151-degrader-antibody-conjugate-discontinued/https://pharmadigest.net/ja/articles/2026-09-21-hdac-tumor-conditional-conjugate-panobinostat/https://pharmadigest.net/ja/articles/2026-09-21-hsc70tac-chaperone-mediated-autophagy-degrader/https://pharmadigest.net/ja/articles/2026-09-21-nav18-benzimidazole-tetrahydrofuran-pain-inhibitor/https://pharmadigest.net/ja/articles/2026-09-21-novartis-lifonebart-als-phase2-failure/https://pharmadigest.net/ja/articles/2026-09-21-novo-nordisk-rebrand-novo/https://pharmadigest.net/ja/articles/2026-09-21-pi3ka-h1047r-mutant-selective-inhibitor/https://pharmadigest.net/ja/articles/2026-09-21-reaps-geometric-deep-learning-peptide-design/https://pharmadigest.net/ja/articles/2026-09-21-roche-genentech-boston-innovation-center/https://pharmadigest.net/ja/articles/2026-09-21-shp2-lysine-covalent-fragment-allosteric-latch/https://pharmadigest.net/ja/articles/2026-09-21-vhl-protac-egfr-degrader-nsclc/https://pharmadigest.net/ja/articles/2026-09-22-alkermes-alks7290-orexin-adhd-phase1b/https://pharmadigest.net/ja/articles/2026-09-22-aoh1996-pcna-second-generation-analogues/https://pharmadigest.net/ja/articles/2026-09-22-biontech-genentech-cevumeran-colorectal-trial-halt/https://pharmadigest.net/ja/articles/2026-09-22-caspase1-dihydropyridine-antagonists/https://pharmadigest.net/ja/articles/2026-09-22-ck1delta-nras-melanoma-degrader/https://pharmadigest.net/ja/articles/2026-09-22-del-ml-physics-generalizability-benchmark/https://pharmadigest.net/ja/articles/2026-09-22-hbv-capsid-ai-multi-objective-optimization/https://pharmadigest.net/ja/articles/2026-09-22-hutchmed-gsk-kras-egfr-attc-license/https://pharmadigest.net/ja/articles/2026-09-22-muscarinic-m3-histamine-h1-bifunctional-rhinitis/https://pharmadigest.net/ja/articles/2026-09-22-novo-nordisk-capital-markets-day-2030-strategy/https://pharmadigest.net/ja/articles/2026-09-22-parp1-ck2a-dual-inhibitor-hrd-independent/https://pharmadigest.net/ja/articles/2026-09-22-protac-oral-absorption-computational-score/https://pharmadigest.net/ja/articles/2026-09-22-telix-itm-isotope-merger/https://pharmadigest.net/ja/articles/2026-09-23-ai-driven-hbv-capsid-assembly-modulator/https://pharmadigest.net/ja/articles/2026-09-23-alkermes-orexin-agonist-adhd-phase1b/https://pharmadigest.net/ja/articles/2026-09-23-antibody-hotspot-peptide-influenza-fusion-inhibitors/https://pharmadigest.net/ja/articles/2026-09-23-aoh1996-analogues-pcna-inhibitor/https://pharmadigest.net/ja/articles/2026-09-23-caspase-1-dihydropyridine-antagonists/https://pharmadigest.net/ja/articles/2026-09-23-ck1delta-degrader-nras-melanoma/https://pharmadigest.net/ja/articles/2026-09-23-covalent-bax-inhibitor-cytoprotection/https://pharmadigest.net/ja/articles/2026-09-23-dyrk1a-inhibitor-brain-penetration-alzheimers/https://pharmadigest.net/ja/articles/2026-09-23-iambic-therapeutics-nasdaq-ipo-filing/https://pharmadigest.net/ja/articles/2026-09-23-lexeo-mantle-friedreich-ataxia-acquisition/https://pharmadigest.net/ja/articles/2026-09-23-merck-winrevair-fda-label-hyperion/https://pharmadigest.net/ja/articles/2026-09-23-multiparadigm-docking-benchmark-cofolding/https://pharmadigest.net/ja/articles/2026-09-23-pancreatic-alpha-amylase-inhibitor-diabetes/https://pharmadigest.net/ja/articles/2026-09-23-telix-itm-radiopharma-acquisition/https://pharmadigest.net/ja/articles/2026-09-23-ultralarge-virtual-screening-perspective/https://pharmadigest.net/ja/articles/2026-09-24-bace1-fragment-growing-cysteine-sulfoxide/https://pharmadigest.net/ja/articles/2026-09-24-bayesian-flow-networks-molecular-design/https://pharmadigest.net/ja/articles/2026-09-24-celldex-barzolvolimab-phase3-embarq-csu/https://pharmadigest.net/ja/articles/2026-09-24-crbn-ptp1b-tcptp-degrader/https://pharmadigest.net/ja/articles/2026-09-24-flagship-pioneering-pentagon-biodefense-contract/https://pharmadigest.net/ja/articles/2026-09-24-fragment-optimization-smiles-strategies/https://pharmadigest.net/ja/articles/2026-09-24-gsk-hansoh-adc-china-strategy/https://pharmadigest.net/ja/articles/2026-09-24-incb127443-cdk2-inhibitor/https://pharmadigest.net/ja/articles/2026-09-24-novo-medicare-glp1-bridge-terms/https://pharmadigest.net/ja/articles/2026-09-24-shp2-orthosteric-to-allosteric-azaindole/https://pharmadigest.net/ja/articles/2026-09-24-triazole-stapled-opioid-npff-agonists/https://pharmadigest.net/ja/articles/2026-09-24-trmd-antibacterial-target-review/https://pharmadigest.net/ja/articles/2026-09-24-trpm7-inhibitors-breast-cancer/https://pharmadigest.net/ja/articles/2026-09-27-basecamp-research-series-c-ai-biology-models/https://pharmadigest.net/ja/articles/2026-09-27-brain-penetrant-covalent-bche-inhibitor/https://pharmadigest.net/ja/articles/2026-09-27-dual-parp-gpx4-inhibitors-tnbc/https://pharmadigest.net/ja/articles/2026-09-27-enveda-series-e-ai-natural-medicines/https://pharmadigest.net/ja/articles/2026-09-27-exel-1855-plk4-lead-optimization/https://pharmadigest.net/ja/articles/2026-09-27-generative-ai-stat3-inhibitor-colorectal-cancer/https://pharmadigest.net/ja/articles/2026-09-27-lilly-innocare-china-discovery-collaboration/https://pharmadigest.net/ja/articles/2026-09-27-lilly-onswik-weekly-insulin-fda-approval/https://pharmadigest.net/ja/articles/2026-09-27-nano-protac-fluorinated-lipid-trafficking/https://pharmadigest.net/ja/articles/2026-09-27-novo-nordisk-nanexa-drug-delivery-license/https://pharmadigest.net/ja/articles/2026-09-27-phage-qbeta-glycoconjugate-cancer-vaccine/https://pharmadigest.net/ja/articles/2026-09-27-roche-xofluza-generic-pandemic-licensing/https://pharmadigest.net/ja/articles/2026-09-27-sirna-antibody-oligonucleotide-conjugate-design/https://pharmadigest.net/ja/articles/2026-09-27-stat6-protac-atopic-dermatitis/https://pharmadigest.net/ja/articles/2026-09-28-amgen-dazodalibep-phase3-sjogrens/https://pharmadigest.net/ja/articles/2026-09-28-cell-penetrating-poly-disulfides/https://pharmadigest.net/ja/articles/2026-09-28-covalent-encoded-library-peptide-macrocycles/https://pharmadigest.net/ja/articles/2026-09-28-fluorinated-isoxazolidinone-apoptosis-inducers/https://pharmadigest.net/ja/articles/2026-09-28-imidazolium-bioisostere-methylated-residues/https://pharmadigest.net/ja/articles/2026-09-28-newamsterdam-menarini-obicetrapib-eu-approval/https://pharmadigest.net/ja/articles/2026-09-28-p53-y220c-nanobret-ligand-validation/https://pharmadigest.net/ja/articles/2026-09-28-roche-enicepatide-phase2-diabetes/https://pharmadigest.net/ja/articles/2026-09-28-roche-sefaxersen-phase3-igan/https://pharmadigest.net/ja/articles/2026-09-28-vertex-inaxaplin-phase2b-kidney/https://pharmadigest.net/ja/articles/2026-09-29-abbvie-tavapadon-parkinsons-approval/https://pharmadigest.net/ja/articles/2026-09-29-automated-ligand-nmr-hit-triage/https://pharmadigest.net/ja/articles/2026-09-29-cruzain-cathepsin-l-covalent-fep/https://pharmadigest.net/ja/articles/2026-09-29-csf-penetrant-ttr-stabilizers/https://pharmadigest.net/ja/articles/2026-09-29-direct-to-biology-drug-discovery-platform/https://pharmadigest.net/ja/articles/2026-09-29-kodiak-daybreak-phase3-wamd/https://pharmadigest.net/ja/articles/2026-09-29-lsd1-nucleoside-analogue-response/https://pharmadigest.net/ja/articles/2026-09-29-maruho-bms-sotyktu-japan-partnership/https://pharmadigest.net/ja/articles/2026-09-29-merck-daiichi-ifinatamab-withdrawal/https://pharmadigest.net/ja/articles/2026-09-29-merck-scibrunch-kras-g12d-license/https://pharmadigest.net/ja/articles/2026-09-29-mirum-atebrioz-fop-fda-approval/https://pharmadigest.net/ja/articles/2026-09-29-murb-pet-imaging-bacterial-infection/https://pharmadigest.net/ja/articles/2026-09-30-amatoxin-adc-dhile-payload-sar/https://pharmadigest.net/ja/articles/2026-09-30-avb6-albumin-binder-radiotheranostic-tracers/https://pharmadigest.net/ja/articles/2026-09-30-genentech-earendil-ai-bispecific-collaboration/https://pharmadigest.net/ja/articles/2026-09-30-melittin-wikrk-repeat-beta-sheet-peptides/https://pharmadigest.net/ja/articles/2026-09-30-mirum-brelovitug-hepatitis-delta-phase3/https://pharmadigest.net/ja/articles/2026-09-30-ptm-binding-free-energy-plac-dataset/https://pharmadigest.net/ja/articles/2026-09-30-siderophore-carbapenem-mbl-inhibitor-conjugates/https://pharmadigest.net/ja/articles/2026-09-30-tolerance-tanabe-il33-antibody-license/https://pharmadigest.net/ja/articles/2026-10-01-astrazeneca-summit-ivonescimab-adc-investment/https://pharmadigest.net/ja/articles/2026-10-01-azaphilone-lysine-covalent-probe-bacteria/https://pharmadigest.net/ja/articles/2026-10-01-ca-ix-aryl-sulfamate-sar/https://pharmadigest.net/ja/articles/2026-10-01-cereblon-protac-prodrug-synthesis/https://pharmadigest.net/ja/articles/2026-10-01-dna-glycosylase-hts-inhibitor-dataset/https://pharmadigest.net/ja/articles/2026-10-01-gba2-covalent-cyclitol-aziridine-inhibitors/https://pharmadigest.net/ja/articles/2026-10-01-merck-recarbrio-us-withdrawal/https://pharmadigest.net/ja/articles/2026-10-01-novo-hengrui-oral-glp1-gip-license/https://pharmadigest.net/ja/articles/2026-10-01-roche-emugrobart-obesity-discontinued/https://pharmadigest.net/ja/articles/2026-10-01-rxfp4-gut-restricted-agonists-constipation/https://pharmadigest.net/ja/articles/2026-10-02-bmtacs-bbb-macrocyclic-dapk1-degraders/https://pharmadigest.net/ja/articles/2026-10-02-boltz2-cofolding-akr1b10-virtual-screening/https://pharmadigest.net/ja/articles/2026-10-02-dt-9081-ep4-antagonist-scaffold-hopping/https://pharmadigest.net/ja/articles/2026-10-02-grp78-isoform-selective-direct-to-biology/https://pharmadigest.net/ja/articles/2026-10-02-hdac8-compact-two-in-one-protac/https://pharmadigest.net/ja/articles/2026-10-02-lilly-eloratzp-amylin-tirzepatide-phase2b/https://pharmadigest.net/ja/articles/2026-10-02-native-ms-protac-ternary-linker-ligand-brd4/https://pharmadigest.net/ja/articles/2026-10-02-nav17-quinazoline-microed-neuropathic-pain/https://pharmadigest.net/ja/articles/2026-10-02-p300-cbp-inhibitors-vs-bifunctional-modalities/https://pharmadigest.net/ja/articles/2026-10-02-sanofi-regeneron-alliance-expansion-four-antibodies/https://pharmadigest.net/ja/articles/2026-10-03-covalent-map2k4-7-pdac/https://pharmadigest.net/ja/articles/2026-10-03-hiv-nnrti-jk4b-entrance-channel/https://pharmadigest.net/ja/articles/2026-10-03-induced-proximity-o-glcnacylation/https://pharmadigest.net/ja/articles/2026-10-03-kit-selective-class-iii-rtk/https://pharmadigest.net/ja/articles/2026-10-03-novartis-abogen-mrna-tce/https://pharmadigest.net/ja/articles/2026-10-03-oral-glp1-small-molecule-agonists-review/https://pharmadigest.net/ja/articles/2026-10-03-scope-concept-hit-finding/https://pharmadigest.net/ja/articles/2026-10-03-tce-coiled-coil-protease-activation/https://pharmadigest.net/ja/articles/2026-10-04-boehringer-zealand-survodutide-phase3-tolerability/https://pharmadigest.net/ja/articles/2026-10-04-despot-anisotropic-scoring-potentials/https://pharmadigest.net/ja/articles/2026-10-04-gtac-gpcr-antagonism-receptor-degradation/https://pharmadigest.net/ja/articles/2026-10-04-lb10-cd73-inhibitor-lung-cancer/https://pharmadigest.net/ja/articles/2026-10-04-novo-orbis-oral-macrocycle-cardiometabolic-deal/https://pharmadigest.net/ja/articles/2026-10-04-protac-linker-analogue-scoring-vhl-shp2/https://pharmadigest.net/ja/articles/2026-10-04-soft-drugs-design-principles-topical/https://pharmadigest.net/ja/articles/2026-10-05-click-triggered-cope-elimination-michael-acceptor-activation/https://pharmadigest.net/ja/articles/2026-10-05-dna-origami-barnase-rna-degrader-mutant-kras-mrna/https://pharmadigest.net/ja/articles/2026-10-05-gspt1-glue-lgne29-glioblastoma/https://pharmadigest.net/ja/articles/2026-10-05-jcr-italfarmaco-izcargo-jr-141-license/https://pharmadigest.net/ja/articles/2026-10-05-kpb82-acer2-inhibitor-doxorubicin-protection/https://pharmadigest.net/ja/articles/2026-10-05-pappa-phosphinate-phosphonate-inhibitors-igf-signaling/https://pharmadigest.net/ja/articles/2026-10-05-summit-astrazeneca-daiichi-ivonescimab-datroway-tnbc-collaboration/https://pharmadigest.net/ja/articles/2026-10-06-csl-alentis-lixudebart-claudin-1-partnership/https://pharmadigest.net/ja/articles/2026-10-06-fto-inhibitors-pyridazine-nicotinamide-aml/https://pharmadigest.net/ja/articles/2026-10-06-genmab-rina-s-ovarian-phase2-vs-elahere/https://pharmadigest.net/ja/articles/2026-10-06-lilly-jaypirca-first-line-cll-approval/https://pharmadigest.net/ja/articles/2026-10-06-nsd2-gspt1-single-atom-degrader-selectivity/https://pharmadigest.net/ja/articles/2026-10-06-pan-ythdf-ligands-structure-based-design/https://pharmadigest.net/ja/articles/2026-10-06-photoactivatable-vegfr2-inhibitors-retina/https://pharmadigest.net/ja/articles/2026-10-06-shionogi-intrabio-acquisition-aqneursa/https://pharmadigest.net/ja/articles/2026-10-07-egfr-protac-hqy1480-macrocyclic-bi4020/https://pharmadigest.net/ja/articles/2026-10-07-genentech-alector-al050-gcase-parkinsons-license/https://pharmadigest.net/ja/articles/2026-10-07-hipk4-cyanoquinoline-inhibitors-male-contraception/https://pharmadigest.net/ja/articles/2026-10-07-lycia-lytac-extracellular-degrader-ipo-filing/https://pharmadigest.net/ja/articles/2026-10-07-merck-scibrunch-kras-g12d-spr2015-license/https://pharmadigest.net/ja/articles/2026-10-07-nlrp3-thienopyrimidinone-istradefylline-colitis/https://pharmadigest.net/ja/articles/2026-10-07-ogg1-organocatalytic-switches-mitochondria-neuroprotection/https://pharmadigest.net/ja/articles/2026-10-07-pkmyt1-4-aminoquinazoline-ccne1-donor-acceptor/https://pharmadigest.net/ja/articles/2026-10-08-astrazeneca-kendall-square-boston-rd-site/https://pharmadigest.net/ja/articles/2026-10-08-caribou-biosciences-wind-down-car-t/https://pharmadigest.net/ja/articles/2026-10-08-chiral-imidazoquinoline-tlr7-8-agonist-antagonist/https://pharmadigest.net/ja/articles/2026-10-08-dengue-ns4b-structure-guided-inhibitor-3dqsar/https://pharmadigest.net/ja/articles/2026-10-08-lanosterol-derivative-bbb-abeta-aggregation-alzheimers/https://pharmadigest.net/ja/articles/2026-10-08-pkmyt1-carboxamide-inhibitors-patent-overview/https://pharmadigest.net/ja/articles/2026-10-09-docking-accuracy-vs-number-of-crystal-structures/https://pharmadigest.net/ja/articles/2026-10-09-forbion-raises-2-6-billion-fund/https://pharmadigest.net/ja/articles/2026-10-09-frespaciguat-mk-5475-inhaled-sgc-stimulator/https://pharmadigest.net/ja/articles/2026-10-09-merck-keytruda-subcutaneous-dutch-court-halt/https://pharmadigest.net/ja/articles/2026-10-09-perk-inhibitor-apl-11056-clinical-candidate/https://pharmadigest.net/ja/articles/2026-10-09-polq-polymerase-inhibitors-benzimidazoles-purines/https://pharmadigest.net/ja/articles/2026-10-09-roche-defand-molecular-glue-discovery-deal/https://pharmadigest.net/ja/articles/2026-10-09-sulfonium-echinocandins-cryptococcus/https://pharmadigest.net/ja/articles/2026-10-09-ulk1-selective-protac-kras-mutant-cancer/https://pharmadigest.net/ja/articles/2026-10-10-argenx-vyvgart-sjogrens-phase3-failure/https://pharmadigest.net/ja/articles/2026-10-10-arrivent-furvent-phase3-firmonertinib-miss/https://pharmadigest.net/ja/articles/2026-10-10-brain-penetrant-colchicine-site-ligand-glioma/https://pharmadigest.net/ja/articles/2026-10-10-dnmt1-protac-b7-liver-fibrosis/https://pharmadigest.net/ja/articles/2026-10-10-enpp1-boronic-acid-inhibitors-ph-resilient/https://pharmadigest.net/ja/articles/2026-10-10-fragdockrl-reinforcement-learning-fragment-design/https://pharmadigest.net/ja/articles/2026-10-10-hdac2-selective-inhibitor-ktt-1-kinetics/https://pharmadigest.net/ja/articles/2026-10-10-hsp90b-chimeric-selective-inhibitors/https://pharmadigest.net/ja/articles/2026-10-10-maglistat-del-hit-magli-432-five-star-matrix/https://pharmadigest.net/ja/articles/2026-10-10-qpct-l-inhibitors-virtual-screening-bi-3614/https://pharmadigest.net/ja/articles/2026-10-12-donepezil-based-dual-buche-faah-inhibitors/https://pharmadigest.net/ja/articles/2026-10-12-flexenn-gnn-binding-energy-disordered-proteins/https://pharmadigest.net/ja/articles/2026-10-12-lactam-bridged-peptide-il-11-antagonist/https://pharmadigest.net/ja/articles/2026-10-12-lasb-hydroxamate-inhibitors-ktgs/https://pharmadigest.net/ja/articles/2026-10-12-life-biosciences-glaucoma-reprogramming-update/https://pharmadigest.net/ja/articles/2026-10-12-lrrk2-g2019s-selective-indazole-bicyclic/https://pharmadigest.net/ja/articles/2026-10-12-masked-bisphosphonate-acid-sphingomyelinase-inhibitors/https://pharmadigest.net/ja/articles/2026-10-12-siderophore-ampicillin-conjugate-pseudomonas/https://pharmadigest.net/ja/articles/2026-10-12-viatris-pacira-non-opioid-pain-acquisition/https://pharmadigest.net/ja/articles/2026-10-13-ferulic-acid-protac-tlr4-degradation-endothelium/https://pharmadigest.net/ja/articles/2026-10-13-gpr183-g-protein-biased-agonist-tug-2604/https://pharmadigest.net/ja/articles/2026-10-13-kdm6b-diaryl-pyrimidine-guanidine-cervical-cancer/https://pharmadigest.net/ja/articles/2026-10-13-mor-d3r-dual-target-ligands-ls01-64-opioid/https://pharmadigest.net/ja/articles/2026-10-13-stk33-inhibitors-cdd-3094-male-contraception/https://pharmadigest.net/ja/articles/2026-10-13-vhl-hdac6-protacs-solid-phase-linker-sar/https://pharmadigest.net/ja/articles/2026-10-14-benzothiophene-mprb-antivirulence-tuberculosis/https://pharmadigest.net/ja/articles/2026-10-14-dcl1191-tfeb-inhibitor-from-eltrombopag/https://pharmadigest.net/ja/articles/2026-10-14-hdac6-l2-pocket-inhibitors-lung-cancer/https://pharmadigest.net/ja/articles/2026-10-14-neurocrine-vykat-xr-prader-willi-safety-concerns/https://pharmadigest.net/ja/articles/2026-10-14-pdia3-n-hydroxyindole-carboxamide-antivirals/https://pharmadigest.net/ja/articles/2026-10-14-peptide-like-del-403200-compounds-diversity/https://pharmadigest.net/ja/articles/2026-10-14-pi4kiiib-hdac-dual-inhibitors-hcv/https://pharmadigest.net/ja/articles/2026-10-14-sting-inhibitor-d4-severe-acute-pancreatitis/https://pharmadigest.net/ja/articles/2026-10-14-tubulin-hdac8-dual-inhibitor-millepachine-ovarian/https://pharmadigest.net/ja/articles/2026-10-15-chd4-macrocycle-nurd-interaction-hub/https://pharmadigest.net/ja/articles/2026-10-15-cinchona-ammonium-long-acting-nerve-block/https://pharmadigest.net/ja/articles/2026-10-15-covalent-fragment-lysine-shp2-latch-site/https://pharmadigest.net/ja/articles/2026-10-15-del-ml-docking-cofolding-generalizability/https://pharmadigest.net/ja/articles/2026-10-15-gtp-state-kras-g12c-covalent-keto-indolizine/https://pharmadigest.net/ja/articles/2026-10-15-lrrk2-g2019s-selective-octahydrocyclopentapyrrole/https://pharmadigest.net/ja/articles/2026-10-15-oral-stat6-degrader-ww-210-atopic-dermatitis/https://pharmadigest.net/ja/articles/2026-10-15-sanofi-eu-antitrust-flu-vaccine-commitments/https://pharmadigest.net/ja/articles/2026-10-16-anti-apoptotic-bax-inhibitors-egfr-scaffold/https://pharmadigest.net/ja/articles/2026-10-16-bcl6-protac-oxazinoquinolinone-dlbcl/https://pharmadigest.net/ja/articles/2026-10-16-cysteine-reactive-early-mitotic-inhibitors/https://pharmadigest.net/ja/articles/2026-10-16-elevenostat-not-hdac11-selective-probe/https://pharmadigest.net/ja/articles/2026-10-16-gilead-vir-dual-masked-t-cell-engagers/https://pharmadigest.net/ja/articles/2026-10-16-gta182-mta-cooperative-prmt5-cns/https://pharmadigest.net/ja/articles/2026-10-16-nav17-aminopyrimidine-state-independent-probe/https://pharmadigest.net/ja/articles/2026-10-16-pfizer-enodia-sec61-inhibitors/https://pharmadigest.net/ja/articles/2026-10-16-roche-rona-alk7-rnai-obesity/https://pharmadigest.net/ja/articles/2026-10-16-slc6a19-allosteric-inhibitors-oral/https://pharmadigest.net/ja/articles/2026-10-16-tau-lrp1-hts-small-molecule-inhibitors/https://pharmadigest.net/ja/articles/2026-10-16-verastem-vs-7375-kras-g12d-pancreatic/https://pharmadigest.net/ja/articles/2026-10-16-zealand-generate-multispecific-obesity/https://pharmadigest.net/ja/articles/2026-10-17-astrazeneca-insitro-ai-target-discovery-deal/https://pharmadigest.net/ja/articles/2026-10-17-brain-penetrant-egfr-tki-crystal-structures/https://pharmadigest.net/ja/articles/2026-10-17-cereblon-cys287-allosteric-covalent-inhibitor/https://pharmadigest.net/ja/articles/2026-10-17-hdac11-yp200-indole-hydroxamate-nsclc/https://pharmadigest.net/ja/articles/2026-10-17-merck-moderna-mrna-cancer-vaccine-keytruda-strategy/https://pharmadigest.net/ja/articles/2026-10-17-mrgprx2-pyrazolopyrimidine-incb187175/https://pharmadigest.net/ja/articles/2026-10-17-revmed-rasonque-eu-approval-recommendation/https://pharmadigest.net/ja/articles/2026-10-17-rhoj-n-terminal-pocket-terconazole/https://pharmadigest.net/ja/articles/2026-10-17-rpt04402-pp2a-molecular-glue-uterine-cancer/https://pharmadigest.net/ja/articles/2026-10-17-ttbk1-2-5-azaindole-probe-ciliogenesis/https://pharmadigest.net/ja/articles/2026-10-17-vg-3927-oral-trem2-agonist-alzheimers/https://pharmadigest.net/ja/articles/2026-10-18-benzodiazepine-antimalarial-pfset3-g9a/https://pharmadigest.net/ja/articles/2026-10-18-bptf-phd-bromodomain-bivalent-inhibitor/https://pharmadigest.net/ja/articles/2026-10-18-lakefront-armed-cell-car-t-programs-sale/https://pharmadigest.net/ja/articles/2026-10-18-myc-de-novo-protein-binders-tumor-growth/https://pharmadigest.net/ja/articles/2026-10-18-pd-qsar-quantile-potency-extrapolation/https://pharmadigest.net/ja/articles/2026-10-18-rab27a-macrocyclic-peptide-effector-free-crystal/https://pharmadigest.net/ja/articles/2026-10-19-charmm-gui-covalent-ligand-docker-autodock4/https://pharmadigest.net/ja/articles/2026-10-19-chemophototherapy-repurposed-anthracenediones-photosensitizers/https://pharmadigest.net/ja/articles/2026-10-19-hsa-fe4-ferric-agent-triple-negative-breast-cancer/https://pharmadigest.net/ja/articles/2026-10-19-lilly-gate-bioscience-sec61-collaboration-expansion/https://pharmadigest.net/ja/articles/2026-10-20-epoxysuccinate-covalent-sars-cov-2-plpro-inhibitors/https://pharmadigest.net/ja/articles/2026-10-20-gilead-emvistegrast-swift-phase2-ulcerative-colitis/https://pharmadigest.net/ja/articles/2026-10-20-isg15-uba7-alphalisa-high-throughput-screen/https://pharmadigest.net/ja/articles/2026-10-20-kinase-inhibitor-protonation-tautomer-shifts-mcce/https://pharmadigest.net/ja/articles/2026-10-20-merck-kgaa-silence-therapeutics-acquisition/https://pharmadigest.net/ja/articles/2026-10-20-parp1-selective-cns-penetrant-triazolopyridinyl-piperazine/https://pharmadigest.net/ja/articles/2026-10-20-protac-unbound-exposure-e3-target-engagement/https://pharmadigest.net/ja/articles/2026-10-21-cenpb-oligotac-dna-protac-nsclc/https://pharmadigest.net/ja/articles/2026-10-21-china-draft-curbs-foreign-biopharma-acquisitions/https://pharmadigest.net/ja/articles/2026-10-21-dcn1-ube2m-inhibitor-herg-reduction/https://pharmadigest.net/ja/articles/2026-10-21-fgfr3-selective-inhibitors-perspective/https://pharmadigest.net/ja/articles/2026-10-21-iwy357-pyrazine-carboxamide-antimalarial/https://pharmadigest.net/ja/articles/2026-10-21-sf-ga-pgp-substrate-to-nonsubstrate-redesign/https://pharmadigest.net/ja/articles/2026-10-22-cofolding-models-ligand-placement-vs-protein-conformation/https://pharmadigest.net/ja/articles/2026-10-22-gsk-fda-approval-hepatitis-b-functional-cure/https://pharmadigest.net/ja/articles/2026-10-22-inhaled-ddr-inhibitors-pyrrolopyrimidine-ipf/https://pharmadigest.net/ja/articles/2026-10-22-macrocyclic-cdk7-pyrazolotriazine-oral-selective/https://pharmadigest.net/ja/articles/2026-10-22-mkk3-non-atp-competitive-modulators-ulcerative-colitis/https://pharmadigest.net/ja/articles/2026-10-22-roche-hansoh-adc-portfolio-collaboration/https://pharmadigest.net/ja/articles/2026-10-22-roivant-positive-trial-non-infectious-uveitis/https://pharmadigest.net/ja/articles/2026-10-22-ttk-monovalent-degrader-monomethyl-fumarate-rnf126/https://pharmadigest.net/ja/articles/2026-10-22-ube2d2-electrophile-first-covalent-aminothiazole/https://pharmadigest.net/ja/articles/2026-10-22-yks-34-pde4b-selective-ipf/https://pharmadigest.net/ja/articles/2026-10-23-aimnet2-cpcm-ligand-strain-solvated/https://pharmadigest.net/ja/articles/2026-10-23-bcl9-beta-catenin-inhibitor-glioma/https://pharmadigest.net/ja/articles/2026-10-23-brd9-protac-mouse-crbn-vhl-species-gap/https://pharmadigest.net/ja/articles/2026-10-23-isomorphic-labs-valuation-ai-drug-discovery/https://pharmadigest.net/ja/articles/2026-10-23-lilly-metis-ai-lnp-delivery-deal/https://pharmadigest.net/ja/articles/2026-10-23-pyrroloquinoline-antitubulin-drug-resistant/https://pharmadigest.net/ja/articles/2026-10-23-sting-inhibitor-tetrahydropyrazolopyrazine-oral/https://pharmadigest.net/ja/articles/2026-10-23-tlr7-tlr8-pyridone-indole-antagonists-brd4-offtarget/https://pharmadigest.net/ja/computational/https://pharmadigest.net/ja/computational/archive/https://pharmadigest.net/ja/computational/archive/2026/09/https://pharmadigest.net/ja/computational/archive/2026/10/https://pharmadigest.net/ja/digest/2026-08-31/https://pharmadigest.net/ja/digest/2026-09-01/https://pharmadigest.net/ja/digest/2026-09-02/https://pharmadigest.net/ja/digest/2026-09-03/https://pharmadigest.net/ja/digest/2026-09-11/https://pharmadigest.net/ja/digest/2026-09-12/https://pharmadigest.net/ja/digest/2026-09-13/https://pharmadigest.net/ja/digest/2026-09-14/https://pharmadigest.net/ja/digest/2026-09-15/https://pharmadigest.net/ja/digest/2026-09-16/https://pharmadigest.net/ja/digest/2026-09-17/https://pharmadigest.net/ja/digest/2026-09-18/https://pharmadigest.net/ja/digest/2026-09-19/https://pharmadigest.net/ja/digest/2026-09-21/https://pharmadigest.net/ja/digest/2026-09-22/https://pharmadigest.net/ja/digest/2026-09-23/https://pharmadigest.net/ja/digest/2026-09-24/https://pharmadigest.net/ja/digest/2026-09-27/https://pharmadigest.net/ja/digest/2026-09-28/https://pharmadigest.net/ja/digest/2026-09-29/https://pharmadigest.net/ja/digest/2026-09-30/https://pharmadigest.net/ja/digest/2026-10-01/https://pharmadigest.net/ja/digest/2026-10-02/https://pharmadigest.net/ja/digest/2026-10-03/https://pharmadigest.net/ja/digest/2026-10-04/https://pharmadigest.net/ja/digest/2026-10-05/https://pharmadigest.net/ja/digest/2026-10-06/https://pharmadigest.net/ja/digest/2026-10-07/https://pharmadigest.net/ja/digest/2026-10-08/https://pharmadigest.net/ja/digest/2026-10-09/https://pharmadigest.net/ja/digest/2026-10-10/https://pharmadigest.net/ja/digest/2026-10-12/https://pharmadigest.net/ja/digest/2026-10-13/https://pharmadigest.net/ja/digest/2026-10-14/https://pharmadigest.net/ja/digest/2026-10-15/https://pharmadigest.net/ja/digest/2026-10-16/https://pharmadigest.net/ja/digest/2026-10-17/https://pharmadigest.net/ja/digest/2026-10-18/https://pharmadigest.net/ja/digest/2026-10-19/https://pharmadigest.net/ja/digest/2026-10-20/https://pharmadigest.net/ja/digest/2026-10-21/https://pharmadigest.net/ja/digest/2026-10-22/https://pharmadigest.net/ja/digest/2026-10-23/https://pharmadigest.net/ja/disclaimer/https://pharmadigest.net/ja/industry/https://pharmadigest.net/ja/industry/archive/https://pharmadigest.net/ja/industry/archive/2026/08/https://pharmadigest.net/ja/industry/archive/2026/09/https://pharmadigest.net/ja/industry/archive/2026/10/https://pharmadigest.net/ja/medchem/https://pharmadigest.net/ja/medchem/archive/https://pharmadigest.net/ja/medchem/archive/2026/09/https://pharmadigest.net/ja/medchem/archive/2026/10/https://pharmadigest.net/ja/pharmacology/https://pharmadigest.net/ja/pharmacology/archive/https://pharmadigest.net/ja/pharmacology/archive/2026/09/https://pharmadigest.net/ja/pharmacology/archive/2026/10/https://pharmadigest.net/ja/privacy/https://pharmadigest.net/ja/search/https://pharmadigest.net/ja/sources/https://pharmadigest.net/ja/terms/https://pharmadigest.net/ja/topics/https://pharmadigest.net/ja/topics/adc/https://pharmadigest.net/ja/topics/ai-ml/https://pharmadigest.net/ja/topics/antibodies/https://pharmadigest.net/ja/topics/cardiovascular/https://pharmadigest.net/ja/topics/cell-gene-therapy/https://pharmadigest.net/ja/topics/chemical-biology/https://pharmadigest.net/ja/topics/china-biotech/https://pharmadigest.net/ja/topics/clinical-readouts/https://pharmadigest.net/ja/topics/clinical-readouts/2/https://pharmadigest.net/ja/topics/covalent/https://pharmadigest.net/ja/topics/del/https://pharmadigest.net/ja/topics/dmpk/https://pharmadigest.net/ja/topics/drug-repurposing/https://pharmadigest.net/ja/topics/epigenetics/https://pharmadigest.net/ja/topics/fbdd/https://pharmadigest.net/ja/topics/financing/https://pharmadigest.net/ja/topics/gpcrs/https://pharmadigest.net/ja/topics/hit-finding/https://pharmadigest.net/ja/topics/immune-checkpoints/https://pharmadigest.net/ja/topics/immunology/https://pharmadigest.net/ja/topics/immunology/2/https://pharmadigest.net/ja/topics/infectious-disease/https://pharmadigest.net/ja/topics/infectious-disease/2/https://pharmadigest.net/ja/topics/kinases/https://pharmadigest.net/ja/topics/kinases/2/https://pharmadigest.net/ja/topics/lead-optimization/https://pharmadigest.net/ja/topics/lead-optimization/2/https://pharmadigest.net/ja/topics/lead-optimization/3/https://pharmadigest.net/ja/topics/licensing-partnerships/https://pharmadigest.net/ja/topics/licensing-partnerships/2/https://pharmadigest.net/ja/topics/m-and-a/https://pharmadigest.net/ja/topics/metabolic/https://pharmadigest.net/ja/topics/molecular-simulation/https://pharmadigest.net/ja/topics/neuroscience/https://pharmadigest.net/ja/topics/neuroscience/2/https://pharmadigest.net/ja/topics/oligonucleotides/https://pharmadigest.net/ja/topics/oncology/https://pharmadigest.net/ja/topics/oncology/2/https://pharmadigest.net/ja/topics/oncology/3/https://pharmadigest.net/ja/topics/oncology/4/https://pharmadigest.net/ja/topics/peptides/https://pharmadigest.net/ja/topics/ppi/https://pharmadigest.net/ja/topics/protein-degradation/https://pharmadigest.net/ja/topics/protein-degradation/2/https://pharmadigest.net/ja/topics/ras/https://pharmadigest.net/ja/topics/regulatory/https://pharmadigest.net/ja/topics/restructuring/https://pharmadigest.net/ja/topics/structure-based-design/https://pharmadigest.net/ja/topics/synthesis/https://pharmadigest.net/ja/topics/virtual-screening/https://pharmadigest.net/zh/https://pharmadigest.net/zh/archive/https://pharmadigest.net/zh/archive/2026/https://pharmadigest.net/zh/archive/2026/08/https://pharmadigest.net/zh/archive/2026/09/https://pharmadigest.net/zh/archive/2026/10/https://pharmadigest.net/zh/articles/2026-08-31-alnylam-astrazeneca-wainua-attr-cm-trial-failure/https://pharmadigest.net/zh/articles/2026-08-31-genentech-dualitybio-adc-payload-deal/https://pharmadigest.net/zh/articles/2026-09-01-novartis-bms-autoimmune-car-t-trial-pause/https://pharmadigest.net/zh/articles/2026-09-02-alumis-envudeucitinib-lupus-trial-miss/https://pharmadigest.net/zh/articles/2026-09-02-eli-lilly-merida-biosciences-acquisition/https://pharmadigest.net/zh/articles/2026-09-02-novartis-remibrutinib-multiple-sclerosis-phase3/https://pharmadigest.net/zh/articles/2026-09-02-uniqure-amt130-huntingtons-bla-submission/https://pharmadigest.net/zh/articles/2026-09-03-arpa-h-rna-manufacturing-give-program-funding/https://pharmadigest.net/zh/articles/2026-09-03-fiz1-molecular-glue-thalidomide-degrader/https://pharmadigest.net/zh/articles/2026-09-03-gsk-mrna-flu-vaccine-phase3-dual-ha-na/https://pharmadigest.net/zh/articles/2026-09-03-roche-simcere-zaiming-sim0660-trispecific-license/https://pharmadigest.net/zh/articles/2026-09-03-tscan-therapeutics-workforce-cut-solid-tumor-pivot/https://pharmadigest.net/zh/articles/2026-09-03-ultragenyx-angelman-apazunersen-phase3-failure/https://pharmadigest.net/zh/articles/2026-09-11-aerobactin-aztreonam-siderophore-conjugate/https://pharmadigest.net/zh/articles/2026-09-11-astrazeneca-tozorakimab-copd-phase3/https://pharmadigest.net/zh/articles/2026-09-11-bayer-hyrnuo-fda-approval-expansion/https://pharmadigest.net/zh/articles/2026-09-11-ctmd-metadynamics-hit-triage/https://pharmadigest.net/zh/articles/2026-09-11-dt-9081-ep4-receptor-antagonist/https://pharmadigest.net/zh/articles/2026-09-11-elix-axcelead-tpd-partnership/https://pharmadigest.net/zh/articles/2026-09-11-g-quadruplex-parp1-transcriptional-silencer/https://pharmadigest.net/zh/articles/2026-09-11-grp78-isoform-selective-inhibitor-d2b/https://pharmadigest.net/zh/articles/2026-09-11-hdac8-protac-compact-2in1-degrader/https://pharmadigest.net/zh/articles/2026-09-11-kura-oncology-caspian-therapeutics-spinoff/https://pharmadigest.net/zh/articles/2026-09-11-novartis-del-desiran-dm1-phase3-failure/https://pharmadigest.net/zh/articles/2026-09-11-novartis-pelacarsen-lpa-horizon-failure/https://pharmadigest.net/zh/articles/2026-09-11-novo-nordisk-ziltivekimab-trials-halted/https://pharmadigest.net/zh/articles/2026-09-11-p53-mutant-covalent-stabilizer-rvjb59/https://pharmadigest.net/zh/articles/2026-09-11-phopex-binding-to-release-conjugate-chemistry/https://pharmadigest.net/zh/articles/2026-09-11-schrodinger-tectora-immunology-license/https://pharmadigest.net/zh/articles/2026-09-11-siglec-7-bicyclic-peptide-inhibitors/https://pharmadigest.net/zh/articles/2026-09-11-tri-611-alk-molecular-glue-degrader/https://pharmadigest.net/zh/articles/2026-09-11-twostep-therapeutics-series-a-ts-104/https://pharmadigest.net/zh/articles/2026-09-11-virtual-screening-benchmark-resolution-limits/https://pharmadigest.net/zh/articles/2026-09-12-astrazeneca-etcamah-ctdna-guided-approval/https://pharmadigest.net/zh/articles/2026-09-12-biomarin-voxzogo-hypochondroplasia-phase3/https://pharmadigest.net/zh/articles/2026-09-12-cd38-cns-penetrant-tricyclic-inhibitors/https://pharmadigest.net/zh/articles/2026-09-12-evommune-evo756-atopic-dermatitis-failure/https://pharmadigest.net/zh/articles/2026-09-12-kalirin-rac1-molecular-glue-inhibitor/https://pharmadigest.net/zh/articles/2026-09-12-mapvis-antibiotic-virtual-screening/https://pharmadigest.net/zh/articles/2026-09-12-tideglusib-nata-chemical-probe/https://pharmadigest.net/zh/articles/2026-09-13-astrazeneca-camizestrant-serena-4-trial-miss/https://pharmadigest.net/zh/articles/2026-09-13-b3gat3-first-in-class-hepatocellular-carcinoma-inhibitors/https://pharmadigest.net/zh/articles/2026-09-13-hiv-1-nnrti-entrance-channel-optimization/https://pharmadigest.net/zh/articles/2026-09-13-oral-glp-1-small-molecule-blueprint/https://pharmadigest.net/zh/articles/2026-09-13-pfama1-cryptic-loop-antimalarial-design/https://pharmadigest.net/zh/articles/2026-09-13-scholar-rock-apitegromab-sma-fda-approval/https://pharmadigest.net/zh/articles/2026-09-13-shionogi-cefiderocol-australia-approval/https://pharmadigest.net/zh/articles/2026-09-13-sufex-dna-encoded-macrocyclic-peptide-libraries/https://pharmadigest.net/zh/articles/2026-09-13-vav1-molecular-glue-ai-protein-folding/https://pharmadigest.net/zh/articles/2026-09-14-akr1b10-inhibitors-boltz2-cofolding/https://pharmadigest.net/zh/articles/2026-09-14-homocamptothecin-adc-payload/https://pharmadigest.net/zh/articles/2026-09-14-solstice-oncology-harbour-biomed-ctla4-licensing/https://pharmadigest.net/zh/articles/2026-09-15-biohaven-sk-biopharmaceuticals-opakalim-clinical-hold/https://pharmadigest.net/zh/articles/2026-09-15-bioxcel-teva-bankruptcy-asset-sale/https://pharmadigest.net/zh/articles/2026-09-15-definium-lsd-anxiety-phase3-fda-filing/https://pharmadigest.net/zh/articles/2026-09-15-hts-mcu-activator-cardiac-bioenergetics/https://pharmadigest.net/zh/articles/2026-09-16-akeso-summit-ivonescimab-keytruda-survival/https://pharmadigest.net/zh/articles/2026-09-16-biontech-oncoc4-gotistobart-lung-cancer-survival/https://pharmadigest.net/zh/articles/2026-09-16-bridgebio-oncology-kras-bbo8520-narrowing/https://pharmadigest.net/zh/articles/2026-09-16-chemberta-casp4-virtual-screening-alzheimers/https://pharmadigest.net/zh/articles/2026-09-16-crbn-molecular-glue-wbp4-degrader/https://pharmadigest.net/zh/articles/2026-09-16-cyclic-peptide-protacs-hif1a-vhl-degrader/https://pharmadigest.net/zh/articles/2026-09-16-gpr41-endotoxemia-autophagy-target/https://pharmadigest.net/zh/articles/2026-09-16-merck-kgaa-postera-fertility-acquisition/https://pharmadigest.net/zh/articles/2026-09-16-photoactive-parp1-inhibitors-computational-design/https://pharmadigest.net/zh/articles/2026-09-16-reactive-metallo-scaffolds-prmt1-target-id/https://pharmadigest.net/zh/articles/2026-09-16-thrombin-inhibitor-dynamic-combinatorial-chemistry/https://pharmadigest.net/zh/articles/2026-09-16-trim24-bromodomain-nonhistone-interactome/https://pharmadigest.net/zh/articles/2026-09-16-vera-trutakna-igan-origin3-phase3/https://pharmadigest.net/zh/articles/2026-09-17-bmtac-bbb-permeable-tpd-aging-brain/https://pharmadigest.net/zh/articles/2026-09-17-chemberta-ai-screening-casp4-inhibitors/https://pharmadigest.net/zh/articles/2026-09-17-ctlh-mkln1-e3-ligase-degron-recognition/https://pharmadigest.net/zh/articles/2026-09-17-encoded-therapeutics-series-f-dravet-gene-therapy/https://pharmadigest.net/zh/articles/2026-09-17-gsk-chimagen-trispecific-tce-multiple-myeloma/https://pharmadigest.net/zh/articles/2026-09-17-h-phosphonate-oligonucleotide-sar-platform/https://pharmadigest.net/zh/articles/2026-09-17-hces2a-nir-fluorogenic-probe-inhibitor-discovery/https://pharmadigest.net/zh/articles/2026-09-17-merck-rahway-layoffs-pipeline-cuts/https://pharmadigest.net/zh/articles/2026-09-17-pyridine-chemoselective-bioconjugate-platform/https://pharmadigest.net/zh/articles/2026-09-17-usp7-targeted-protein-stabilization-screening/https://pharmadigest.net/zh/articles/2026-09-17-vera-trutakna-iga-nephropathy-phase3/https://pharmadigest.net/zh/articles/2026-09-17-wbp4-crbn-molecular-glue-degrader/https://pharmadigest.net/zh/articles/2026-09-18-astrazeneca-enhertu-nhs-england-nice-pricing-deal/https://pharmadigest.net/zh/articles/2026-09-18-biontech-oncoc4-gotistobart-phase3-nsclc/https://pharmadigest.net/zh/articles/2026-09-18-cmyc-ribotac-linker-optimization/https://pharmadigest.net/zh/articles/2026-09-18-cyp8b1-quinoline-inhibitors-metabolic-disease/https://pharmadigest.net/zh/articles/2026-09-18-flavonoid-bioisosteric-aromatase-inhibitors/https://pharmadigest.net/zh/articles/2026-09-18-hdac4-hdac7-isoform-selective-th17-inhibitors/https://pharmadigest.net/zh/articles/2026-09-18-keap1-nrf2-cofolding-screening-cascade-benchmarks/https://pharmadigest.net/zh/articles/2026-09-18-merck-kgaa-postera-fertility-acquisition/https://pharmadigest.net/zh/articles/2026-09-18-novo-nordisk-ascendis-glp1-deal-termination/https://pharmadigest.net/zh/articles/2026-09-18-p38delta-self-encapsulating-kinase-inhibitor/https://pharmadigest.net/zh/articles/2026-09-18-sellas-regal-trial-aml-expected-failure/https://pharmadigest.net/zh/articles/2026-09-18-sionna-layoffs-cystic-fibrosis-trial-failure/https://pharmadigest.net/zh/articles/2026-09-18-sling-therapeutics-series-c-linsitinib/https://pharmadigest.net/zh/articles/2026-09-18-stellar-fragment-based-peptide-docking/https://pharmadigest.net/zh/articles/2026-09-18-taar1-agonists-structure-based-discovery/https://pharmadigest.net/zh/articles/2026-09-18-thrombin-inhibitor-dynamic-combinatorial-chemistry/https://pharmadigest.net/zh/articles/2026-09-18-trim24-bromodomain-nonhistone-interactome/https://pharmadigest.net/zh/articles/2026-09-19-ariadne-bio-parkinsons-apathy-launch/https://pharmadigest.net/zh/articles/2026-09-19-astrazeneca-enhertu-nice-england-pricing/https://pharmadigest.net/zh/articles/2026-09-19-hdac4-hdac7-selective-inhibitors-th17/https://pharmadigest.net/zh/articles/2026-09-19-hyreptaones-cav31-calcium-channel-inhibitors/https://pharmadigest.net/zh/articles/2026-09-19-jacs-degrader-antibody-conjugate-tumor-stroma/https://pharmadigest.net/zh/articles/2026-09-19-keap1-nrf2-virtual-screening-stress-test/https://pharmadigest.net/zh/articles/2026-09-19-kinase-catalytic-cluster-residues-structural-survey/https://pharmadigest.net/zh/articles/2026-09-19-longeveron-elpis-ii-phase2b-failure/https://pharmadigest.net/zh/articles/2026-09-19-north-immunology-aethlon-reverse-merger/https://pharmadigest.net/zh/articles/2026-09-19-omaveloxolone-sting-degrader-repurposing/https://pharmadigest.net/zh/articles/2026-09-19-scope-chemical-space-hit-finding/https://pharmadigest.net/zh/articles/2026-09-19-sellas-regal-aml-trial-outlook/https://pharmadigest.net/zh/articles/2026-09-19-sling-therapeutics-series-c-thyroid-eye-disease/https://pharmadigest.net/zh/articles/2026-09-19-ultragenyx-fayuvi-sanfilippo-approval/https://pharmadigest.net/zh/articles/2026-09-21-bms-orum-orm6151-degrader-antibody-conjugate-discontinued/https://pharmadigest.net/zh/articles/2026-09-21-hdac-tumor-conditional-conjugate-panobinostat/https://pharmadigest.net/zh/articles/2026-09-21-hsc70tac-chaperone-mediated-autophagy-degrader/https://pharmadigest.net/zh/articles/2026-09-21-nav18-benzimidazole-tetrahydrofuran-pain-inhibitor/https://pharmadigest.net/zh/articles/2026-09-21-novartis-lifonebart-als-phase2-failure/https://pharmadigest.net/zh/articles/2026-09-21-novo-nordisk-rebrand-novo/https://pharmadigest.net/zh/articles/2026-09-21-pi3ka-h1047r-mutant-selective-inhibitor/https://pharmadigest.net/zh/articles/2026-09-21-reaps-geometric-deep-learning-peptide-design/https://pharmadigest.net/zh/articles/2026-09-21-roche-genentech-boston-innovation-center/https://pharmadigest.net/zh/articles/2026-09-21-shp2-lysine-covalent-fragment-allosteric-latch/https://pharmadigest.net/zh/articles/2026-09-21-vhl-protac-egfr-degrader-nsclc/https://pharmadigest.net/zh/articles/2026-09-22-alkermes-alks7290-orexin-adhd-phase1b/https://pharmadigest.net/zh/articles/2026-09-22-aoh1996-pcna-second-generation-analogues/https://pharmadigest.net/zh/articles/2026-09-22-biontech-genentech-cevumeran-colorectal-trial-halt/https://pharmadigest.net/zh/articles/2026-09-22-caspase1-dihydropyridine-antagonists/https://pharmadigest.net/zh/articles/2026-09-22-ck1delta-nras-melanoma-degrader/https://pharmadigest.net/zh/articles/2026-09-22-del-ml-physics-generalizability-benchmark/https://pharmadigest.net/zh/articles/2026-09-22-hbv-capsid-ai-multi-objective-optimization/https://pharmadigest.net/zh/articles/2026-09-22-hutchmed-gsk-kras-egfr-attc-license/https://pharmadigest.net/zh/articles/2026-09-22-muscarinic-m3-histamine-h1-bifunctional-rhinitis/https://pharmadigest.net/zh/articles/2026-09-22-novo-nordisk-capital-markets-day-2030-strategy/https://pharmadigest.net/zh/articles/2026-09-22-parp1-ck2a-dual-inhibitor-hrd-independent/https://pharmadigest.net/zh/articles/2026-09-22-protac-oral-absorption-computational-score/https://pharmadigest.net/zh/articles/2026-09-22-telix-itm-isotope-merger/https://pharmadigest.net/zh/articles/2026-09-23-ai-driven-hbv-capsid-assembly-modulator/https://pharmadigest.net/zh/articles/2026-09-23-alkermes-orexin-agonist-adhd-phase1b/https://pharmadigest.net/zh/articles/2026-09-23-antibody-hotspot-peptide-influenza-fusion-inhibitors/https://pharmadigest.net/zh/articles/2026-09-23-aoh1996-analogues-pcna-inhibitor/https://pharmadigest.net/zh/articles/2026-09-23-caspase-1-dihydropyridine-antagonists/https://pharmadigest.net/zh/articles/2026-09-23-ck1delta-degrader-nras-melanoma/https://pharmadigest.net/zh/articles/2026-09-23-covalent-bax-inhibitor-cytoprotection/https://pharmadigest.net/zh/articles/2026-09-23-dyrk1a-inhibitor-brain-penetration-alzheimers/https://pharmadigest.net/zh/articles/2026-09-23-iambic-therapeutics-nasdaq-ipo-filing/https://pharmadigest.net/zh/articles/2026-09-23-lexeo-mantle-friedreich-ataxia-acquisition/https://pharmadigest.net/zh/articles/2026-09-23-merck-winrevair-fda-label-hyperion/https://pharmadigest.net/zh/articles/2026-09-23-multiparadigm-docking-benchmark-cofolding/https://pharmadigest.net/zh/articles/2026-09-23-pancreatic-alpha-amylase-inhibitor-diabetes/https://pharmadigest.net/zh/articles/2026-09-23-telix-itm-radiopharma-acquisition/https://pharmadigest.net/zh/articles/2026-09-23-ultralarge-virtual-screening-perspective/https://pharmadigest.net/zh/articles/2026-09-24-bace1-fragment-growing-cysteine-sulfoxide/https://pharmadigest.net/zh/articles/2026-09-24-bayesian-flow-networks-molecular-design/https://pharmadigest.net/zh/articles/2026-09-24-celldex-barzolvolimab-phase3-embarq-csu/https://pharmadigest.net/zh/articles/2026-09-24-crbn-ptp1b-tcptp-degrader/https://pharmadigest.net/zh/articles/2026-09-24-flagship-pioneering-pentagon-biodefense-contract/https://pharmadigest.net/zh/articles/2026-09-24-fragment-optimization-smiles-strategies/https://pharmadigest.net/zh/articles/2026-09-24-gsk-hansoh-adc-china-strategy/https://pharmadigest.net/zh/articles/2026-09-24-incb127443-cdk2-inhibitor/https://pharmadigest.net/zh/articles/2026-09-24-novo-medicare-glp1-bridge-terms/https://pharmadigest.net/zh/articles/2026-09-24-shp2-orthosteric-to-allosteric-azaindole/https://pharmadigest.net/zh/articles/2026-09-24-triazole-stapled-opioid-npff-agonists/https://pharmadigest.net/zh/articles/2026-09-24-trmd-antibacterial-target-review/https://pharmadigest.net/zh/articles/2026-09-24-trpm7-inhibitors-breast-cancer/https://pharmadigest.net/zh/articles/2026-09-27-basecamp-research-series-c-ai-biology-models/https://pharmadigest.net/zh/articles/2026-09-27-brain-penetrant-covalent-bche-inhibitor/https://pharmadigest.net/zh/articles/2026-09-27-dual-parp-gpx4-inhibitors-tnbc/https://pharmadigest.net/zh/articles/2026-09-27-enveda-series-e-ai-natural-medicines/https://pharmadigest.net/zh/articles/2026-09-27-exel-1855-plk4-lead-optimization/https://pharmadigest.net/zh/articles/2026-09-27-generative-ai-stat3-inhibitor-colorectal-cancer/https://pharmadigest.net/zh/articles/2026-09-27-lilly-innocare-china-discovery-collaboration/https://pharmadigest.net/zh/articles/2026-09-27-lilly-onswik-weekly-insulin-fda-approval/https://pharmadigest.net/zh/articles/2026-09-27-nano-protac-fluorinated-lipid-trafficking/https://pharmadigest.net/zh/articles/2026-09-27-novo-nordisk-nanexa-drug-delivery-license/https://pharmadigest.net/zh/articles/2026-09-27-phage-qbeta-glycoconjugate-cancer-vaccine/https://pharmadigest.net/zh/articles/2026-09-27-roche-xofluza-generic-pandemic-licensing/https://pharmadigest.net/zh/articles/2026-09-27-sirna-antibody-oligonucleotide-conjugate-design/https://pharmadigest.net/zh/articles/2026-09-27-stat6-protac-atopic-dermatitis/https://pharmadigest.net/zh/articles/2026-09-28-amgen-dazodalibep-phase3-sjogrens/https://pharmadigest.net/zh/articles/2026-09-28-cell-penetrating-poly-disulfides/https://pharmadigest.net/zh/articles/2026-09-28-covalent-encoded-library-peptide-macrocycles/https://pharmadigest.net/zh/articles/2026-09-28-fluorinated-isoxazolidinone-apoptosis-inducers/https://pharmadigest.net/zh/articles/2026-09-28-imidazolium-bioisostere-methylated-residues/https://pharmadigest.net/zh/articles/2026-09-28-newamsterdam-menarini-obicetrapib-eu-approval/https://pharmadigest.net/zh/articles/2026-09-28-p53-y220c-nanobret-ligand-validation/https://pharmadigest.net/zh/articles/2026-09-28-roche-enicepatide-phase2-diabetes/https://pharmadigest.net/zh/articles/2026-09-28-roche-sefaxersen-phase3-igan/https://pharmadigest.net/zh/articles/2026-09-28-vertex-inaxaplin-phase2b-kidney/https://pharmadigest.net/zh/articles/2026-09-29-abbvie-tavapadon-parkinsons-approval/https://pharmadigest.net/zh/articles/2026-09-29-automated-ligand-nmr-hit-triage/https://pharmadigest.net/zh/articles/2026-09-29-cruzain-cathepsin-l-covalent-fep/https://pharmadigest.net/zh/articles/2026-09-29-csf-penetrant-ttr-stabilizers/https://pharmadigest.net/zh/articles/2026-09-29-direct-to-biology-drug-discovery-platform/https://pharmadigest.net/zh/articles/2026-09-29-kodiak-daybreak-phase3-wamd/https://pharmadigest.net/zh/articles/2026-09-29-lsd1-nucleoside-analogue-response/https://pharmadigest.net/zh/articles/2026-09-29-maruho-bms-sotyktu-japan-partnership/https://pharmadigest.net/zh/articles/2026-09-29-merck-daiichi-ifinatamab-withdrawal/https://pharmadigest.net/zh/articles/2026-09-29-merck-scibrunch-kras-g12d-license/https://pharmadigest.net/zh/articles/2026-09-29-mirum-atebrioz-fop-fda-approval/https://pharmadigest.net/zh/articles/2026-09-29-murb-pet-imaging-bacterial-infection/https://pharmadigest.net/zh/articles/2026-09-30-amatoxin-adc-dhile-payload-sar/https://pharmadigest.net/zh/articles/2026-09-30-avb6-albumin-binder-radiotheranostic-tracers/https://pharmadigest.net/zh/articles/2026-09-30-genentech-earendil-ai-bispecific-collaboration/https://pharmadigest.net/zh/articles/2026-09-30-melittin-wikrk-repeat-beta-sheet-peptides/https://pharmadigest.net/zh/articles/2026-09-30-mirum-brelovitug-hepatitis-delta-phase3/https://pharmadigest.net/zh/articles/2026-09-30-ptm-binding-free-energy-plac-dataset/https://pharmadigest.net/zh/articles/2026-09-30-siderophore-carbapenem-mbl-inhibitor-conjugates/https://pharmadigest.net/zh/articles/2026-09-30-tolerance-tanabe-il33-antibody-license/https://pharmadigest.net/zh/articles/2026-10-01-astrazeneca-summit-ivonescimab-adc-investment/https://pharmadigest.net/zh/articles/2026-10-01-azaphilone-lysine-covalent-probe-bacteria/https://pharmadigest.net/zh/articles/2026-10-01-ca-ix-aryl-sulfamate-sar/https://pharmadigest.net/zh/articles/2026-10-01-cereblon-protac-prodrug-synthesis/https://pharmadigest.net/zh/articles/2026-10-01-dna-glycosylase-hts-inhibitor-dataset/https://pharmadigest.net/zh/articles/2026-10-01-gba2-covalent-cyclitol-aziridine-inhibitors/https://pharmadigest.net/zh/articles/2026-10-01-merck-recarbrio-us-withdrawal/https://pharmadigest.net/zh/articles/2026-10-01-novo-hengrui-oral-glp1-gip-license/https://pharmadigest.net/zh/articles/2026-10-01-roche-emugrobart-obesity-discontinued/https://pharmadigest.net/zh/articles/2026-10-01-rxfp4-gut-restricted-agonists-constipation/https://pharmadigest.net/zh/articles/2026-10-02-bmtacs-bbb-macrocyclic-dapk1-degraders/https://pharmadigest.net/zh/articles/2026-10-02-boltz2-cofolding-akr1b10-virtual-screening/https://pharmadigest.net/zh/articles/2026-10-02-dt-9081-ep4-antagonist-scaffold-hopping/https://pharmadigest.net/zh/articles/2026-10-02-grp78-isoform-selective-direct-to-biology/https://pharmadigest.net/zh/articles/2026-10-02-hdac8-compact-two-in-one-protac/https://pharmadigest.net/zh/articles/2026-10-02-lilly-eloratzp-amylin-tirzepatide-phase2b/https://pharmadigest.net/zh/articles/2026-10-02-native-ms-protac-ternary-linker-ligand-brd4/https://pharmadigest.net/zh/articles/2026-10-02-nav17-quinazoline-microed-neuropathic-pain/https://pharmadigest.net/zh/articles/2026-10-02-p300-cbp-inhibitors-vs-bifunctional-modalities/https://pharmadigest.net/zh/articles/2026-10-02-sanofi-regeneron-alliance-expansion-four-antibodies/https://pharmadigest.net/zh/articles/2026-10-03-covalent-map2k4-7-pdac/https://pharmadigest.net/zh/articles/2026-10-03-hiv-nnrti-jk4b-entrance-channel/https://pharmadigest.net/zh/articles/2026-10-03-induced-proximity-o-glcnacylation/https://pharmadigest.net/zh/articles/2026-10-03-kit-selective-class-iii-rtk/https://pharmadigest.net/zh/articles/2026-10-03-novartis-abogen-mrna-tce/https://pharmadigest.net/zh/articles/2026-10-03-oral-glp1-small-molecule-agonists-review/https://pharmadigest.net/zh/articles/2026-10-03-scope-concept-hit-finding/https://pharmadigest.net/zh/articles/2026-10-03-tce-coiled-coil-protease-activation/https://pharmadigest.net/zh/articles/2026-10-04-boehringer-zealand-survodutide-phase3-tolerability/https://pharmadigest.net/zh/articles/2026-10-04-despot-anisotropic-scoring-potentials/https://pharmadigest.net/zh/articles/2026-10-04-gtac-gpcr-antagonism-receptor-degradation/https://pharmadigest.net/zh/articles/2026-10-04-lb10-cd73-inhibitor-lung-cancer/https://pharmadigest.net/zh/articles/2026-10-04-novo-orbis-oral-macrocycle-cardiometabolic-deal/https://pharmadigest.net/zh/articles/2026-10-04-protac-linker-analogue-scoring-vhl-shp2/https://pharmadigest.net/zh/articles/2026-10-04-soft-drugs-design-principles-topical/https://pharmadigest.net/zh/articles/2026-10-05-click-triggered-cope-elimination-michael-acceptor-activation/https://pharmadigest.net/zh/articles/2026-10-05-dna-origami-barnase-rna-degrader-mutant-kras-mrna/https://pharmadigest.net/zh/articles/2026-10-05-gspt1-glue-lgne29-glioblastoma/https://pharmadigest.net/zh/articles/2026-10-05-jcr-italfarmaco-izcargo-jr-141-license/https://pharmadigest.net/zh/articles/2026-10-05-kpb82-acer2-inhibitor-doxorubicin-protection/https://pharmadigest.net/zh/articles/2026-10-05-pappa-phosphinate-phosphonate-inhibitors-igf-signaling/https://pharmadigest.net/zh/articles/2026-10-05-summit-astrazeneca-daiichi-ivonescimab-datroway-tnbc-collaboration/https://pharmadigest.net/zh/articles/2026-10-06-csl-alentis-lixudebart-claudin-1-partnership/https://pharmadigest.net/zh/articles/2026-10-06-fto-inhibitors-pyridazine-nicotinamide-aml/https://pharmadigest.net/zh/articles/2026-10-06-genmab-rina-s-ovarian-phase2-vs-elahere/https://pharmadigest.net/zh/articles/2026-10-06-lilly-jaypirca-first-line-cll-approval/https://pharmadigest.net/zh/articles/2026-10-06-nsd2-gspt1-single-atom-degrader-selectivity/https://pharmadigest.net/zh/articles/2026-10-06-pan-ythdf-ligands-structure-based-design/https://pharmadigest.net/zh/articles/2026-10-06-photoactivatable-vegfr2-inhibitors-retina/https://pharmadigest.net/zh/articles/2026-10-06-shionogi-intrabio-acquisition-aqneursa/https://pharmadigest.net/zh/articles/2026-10-07-egfr-protac-hqy1480-macrocyclic-bi4020/https://pharmadigest.net/zh/articles/2026-10-07-genentech-alector-al050-gcase-parkinsons-license/https://pharmadigest.net/zh/articles/2026-10-07-hipk4-cyanoquinoline-inhibitors-male-contraception/https://pharmadigest.net/zh/articles/2026-10-07-lycia-lytac-extracellular-degrader-ipo-filing/https://pharmadigest.net/zh/articles/2026-10-07-merck-scibrunch-kras-g12d-spr2015-license/https://pharmadigest.net/zh/articles/2026-10-07-nlrp3-thienopyrimidinone-istradefylline-colitis/https://pharmadigest.net/zh/articles/2026-10-07-ogg1-organocatalytic-switches-mitochondria-neuroprotection/https://pharmadigest.net/zh/articles/2026-10-07-pkmyt1-4-aminoquinazoline-ccne1-donor-acceptor/https://pharmadigest.net/zh/articles/2026-10-08-astrazeneca-kendall-square-boston-rd-site/https://pharmadigest.net/zh/articles/2026-10-08-caribou-biosciences-wind-down-car-t/https://pharmadigest.net/zh/articles/2026-10-08-chiral-imidazoquinoline-tlr7-8-agonist-antagonist/https://pharmadigest.net/zh/articles/2026-10-08-dengue-ns4b-structure-guided-inhibitor-3dqsar/https://pharmadigest.net/zh/articles/2026-10-08-lanosterol-derivative-bbb-abeta-aggregation-alzheimers/https://pharmadigest.net/zh/articles/2026-10-08-pkmyt1-carboxamide-inhibitors-patent-overview/https://pharmadigest.net/zh/articles/2026-10-09-docking-accuracy-vs-number-of-crystal-structures/https://pharmadigest.net/zh/articles/2026-10-09-forbion-raises-2-6-billion-fund/https://pharmadigest.net/zh/articles/2026-10-09-frespaciguat-mk-5475-inhaled-sgc-stimulator/https://pharmadigest.net/zh/articles/2026-10-09-merck-keytruda-subcutaneous-dutch-court-halt/https://pharmadigest.net/zh/articles/2026-10-09-perk-inhibitor-apl-11056-clinical-candidate/https://pharmadigest.net/zh/articles/2026-10-09-polq-polymerase-inhibitors-benzimidazoles-purines/https://pharmadigest.net/zh/articles/2026-10-09-roche-defand-molecular-glue-discovery-deal/https://pharmadigest.net/zh/articles/2026-10-09-sulfonium-echinocandins-cryptococcus/https://pharmadigest.net/zh/articles/2026-10-09-ulk1-selective-protac-kras-mutant-cancer/https://pharmadigest.net/zh/articles/2026-10-10-argenx-vyvgart-sjogrens-phase3-failure/https://pharmadigest.net/zh/articles/2026-10-10-arrivent-furvent-phase3-firmonertinib-miss/https://pharmadigest.net/zh/articles/2026-10-10-brain-penetrant-colchicine-site-ligand-glioma/https://pharmadigest.net/zh/articles/2026-10-10-dnmt1-protac-b7-liver-fibrosis/https://pharmadigest.net/zh/articles/2026-10-10-enpp1-boronic-acid-inhibitors-ph-resilient/https://pharmadigest.net/zh/articles/2026-10-10-fragdockrl-reinforcement-learning-fragment-design/https://pharmadigest.net/zh/articles/2026-10-10-hdac2-selective-inhibitor-ktt-1-kinetics/https://pharmadigest.net/zh/articles/2026-10-10-hsp90b-chimeric-selective-inhibitors/https://pharmadigest.net/zh/articles/2026-10-10-maglistat-del-hit-magli-432-five-star-matrix/https://pharmadigest.net/zh/articles/2026-10-10-qpct-l-inhibitors-virtual-screening-bi-3614/https://pharmadigest.net/zh/articles/2026-10-12-donepezil-based-dual-buche-faah-inhibitors/https://pharmadigest.net/zh/articles/2026-10-12-flexenn-gnn-binding-energy-disordered-proteins/https://pharmadigest.net/zh/articles/2026-10-12-lactam-bridged-peptide-il-11-antagonist/https://pharmadigest.net/zh/articles/2026-10-12-lasb-hydroxamate-inhibitors-ktgs/https://pharmadigest.net/zh/articles/2026-10-12-life-biosciences-glaucoma-reprogramming-update/https://pharmadigest.net/zh/articles/2026-10-12-lrrk2-g2019s-selective-indazole-bicyclic/https://pharmadigest.net/zh/articles/2026-10-12-masked-bisphosphonate-acid-sphingomyelinase-inhibitors/https://pharmadigest.net/zh/articles/2026-10-12-siderophore-ampicillin-conjugate-pseudomonas/https://pharmadigest.net/zh/articles/2026-10-12-viatris-pacira-non-opioid-pain-acquisition/https://pharmadigest.net/zh/articles/2026-10-13-ferulic-acid-protac-tlr4-degradation-endothelium/https://pharmadigest.net/zh/articles/2026-10-13-gpr183-g-protein-biased-agonist-tug-2604/https://pharmadigest.net/zh/articles/2026-10-13-kdm6b-diaryl-pyrimidine-guanidine-cervical-cancer/https://pharmadigest.net/zh/articles/2026-10-13-mor-d3r-dual-target-ligands-ls01-64-opioid/https://pharmadigest.net/zh/articles/2026-10-13-stk33-inhibitors-cdd-3094-male-contraception/https://pharmadigest.net/zh/articles/2026-10-13-vhl-hdac6-protacs-solid-phase-linker-sar/https://pharmadigest.net/zh/articles/2026-10-14-benzothiophene-mprb-antivirulence-tuberculosis/https://pharmadigest.net/zh/articles/2026-10-14-dcl1191-tfeb-inhibitor-from-eltrombopag/https://pharmadigest.net/zh/articles/2026-10-14-hdac6-l2-pocket-inhibitors-lung-cancer/https://pharmadigest.net/zh/articles/2026-10-14-neurocrine-vykat-xr-prader-willi-safety-concerns/https://pharmadigest.net/zh/articles/2026-10-14-pdia3-n-hydroxyindole-carboxamide-antivirals/https://pharmadigest.net/zh/articles/2026-10-14-peptide-like-del-403200-compounds-diversity/https://pharmadigest.net/zh/articles/2026-10-14-pi4kiiib-hdac-dual-inhibitors-hcv/https://pharmadigest.net/zh/articles/2026-10-14-sting-inhibitor-d4-severe-acute-pancreatitis/https://pharmadigest.net/zh/articles/2026-10-14-tubulin-hdac8-dual-inhibitor-millepachine-ovarian/https://pharmadigest.net/zh/articles/2026-10-15-chd4-macrocycle-nurd-interaction-hub/https://pharmadigest.net/zh/articles/2026-10-15-cinchona-ammonium-long-acting-nerve-block/https://pharmadigest.net/zh/articles/2026-10-15-covalent-fragment-lysine-shp2-latch-site/https://pharmadigest.net/zh/articles/2026-10-15-del-ml-docking-cofolding-generalizability/https://pharmadigest.net/zh/articles/2026-10-15-gtp-state-kras-g12c-covalent-keto-indolizine/https://pharmadigest.net/zh/articles/2026-10-15-lrrk2-g2019s-selective-octahydrocyclopentapyrrole/https://pharmadigest.net/zh/articles/2026-10-15-oral-stat6-degrader-ww-210-atopic-dermatitis/https://pharmadigest.net/zh/articles/2026-10-15-sanofi-eu-antitrust-flu-vaccine-commitments/https://pharmadigest.net/zh/articles/2026-10-16-anti-apoptotic-bax-inhibitors-egfr-scaffold/https://pharmadigest.net/zh/articles/2026-10-16-bcl6-protac-oxazinoquinolinone-dlbcl/https://pharmadigest.net/zh/articles/2026-10-16-cysteine-reactive-early-mitotic-inhibitors/https://pharmadigest.net/zh/articles/2026-10-16-elevenostat-not-hdac11-selective-probe/https://pharmadigest.net/zh/articles/2026-10-16-gilead-vir-dual-masked-t-cell-engagers/https://pharmadigest.net/zh/articles/2026-10-16-gta182-mta-cooperative-prmt5-cns/https://pharmadigest.net/zh/articles/2026-10-16-nav17-aminopyrimidine-state-independent-probe/https://pharmadigest.net/zh/articles/2026-10-16-pfizer-enodia-sec61-inhibitors/https://pharmadigest.net/zh/articles/2026-10-16-roche-rona-alk7-rnai-obesity/https://pharmadigest.net/zh/articles/2026-10-16-slc6a19-allosteric-inhibitors-oral/https://pharmadigest.net/zh/articles/2026-10-16-tau-lrp1-hts-small-molecule-inhibitors/https://pharmadigest.net/zh/articles/2026-10-16-verastem-vs-7375-kras-g12d-pancreatic/https://pharmadigest.net/zh/articles/2026-10-16-zealand-generate-multispecific-obesity/https://pharmadigest.net/zh/articles/2026-10-17-astrazeneca-insitro-ai-target-discovery-deal/https://pharmadigest.net/zh/articles/2026-10-17-brain-penetrant-egfr-tki-crystal-structures/https://pharmadigest.net/zh/articles/2026-10-17-cereblon-cys287-allosteric-covalent-inhibitor/https://pharmadigest.net/zh/articles/2026-10-17-hdac11-yp200-indole-hydroxamate-nsclc/https://pharmadigest.net/zh/articles/2026-10-17-merck-moderna-mrna-cancer-vaccine-keytruda-strategy/https://pharmadigest.net/zh/articles/2026-10-17-mrgprx2-pyrazolopyrimidine-incb187175/https://pharmadigest.net/zh/articles/2026-10-17-revmed-rasonque-eu-approval-recommendation/https://pharmadigest.net/zh/articles/2026-10-17-rhoj-n-terminal-pocket-terconazole/https://pharmadigest.net/zh/articles/2026-10-17-rpt04402-pp2a-molecular-glue-uterine-cancer/https://pharmadigest.net/zh/articles/2026-10-17-ttbk1-2-5-azaindole-probe-ciliogenesis/https://pharmadigest.net/zh/articles/2026-10-17-vg-3927-oral-trem2-agonist-alzheimers/https://pharmadigest.net/zh/articles/2026-10-18-benzodiazepine-antimalarial-pfset3-g9a/https://pharmadigest.net/zh/articles/2026-10-18-bptf-phd-bromodomain-bivalent-inhibitor/https://pharmadigest.net/zh/articles/2026-10-18-lakefront-armed-cell-car-t-programs-sale/https://pharmadigest.net/zh/articles/2026-10-18-myc-de-novo-protein-binders-tumor-growth/https://pharmadigest.net/zh/articles/2026-10-18-pd-qsar-quantile-potency-extrapolation/https://pharmadigest.net/zh/articles/2026-10-18-rab27a-macrocyclic-peptide-effector-free-crystal/https://pharmadigest.net/zh/articles/2026-10-19-charmm-gui-covalent-ligand-docker-autodock4/https://pharmadigest.net/zh/articles/2026-10-19-chemophototherapy-repurposed-anthracenediones-photosensitizers/https://pharmadigest.net/zh/articles/2026-10-19-hsa-fe4-ferric-agent-triple-negative-breast-cancer/https://pharmadigest.net/zh/articles/2026-10-19-lilly-gate-bioscience-sec61-collaboration-expansion/https://pharmadigest.net/zh/articles/2026-10-20-epoxysuccinate-covalent-sars-cov-2-plpro-inhibitors/https://pharmadigest.net/zh/articles/2026-10-20-gilead-emvistegrast-swift-phase2-ulcerative-colitis/https://pharmadigest.net/zh/articles/2026-10-20-isg15-uba7-alphalisa-high-throughput-screen/https://pharmadigest.net/zh/articles/2026-10-20-kinase-inhibitor-protonation-tautomer-shifts-mcce/https://pharmadigest.net/zh/articles/2026-10-20-merck-kgaa-silence-therapeutics-acquisition/https://pharmadigest.net/zh/articles/2026-10-20-parp1-selective-cns-penetrant-triazolopyridinyl-piperazine/https://pharmadigest.net/zh/articles/2026-10-20-protac-unbound-exposure-e3-target-engagement/https://pharmadigest.net/zh/articles/2026-10-21-cenpb-oligotac-dna-protac-nsclc/https://pharmadigest.net/zh/articles/2026-10-21-china-draft-curbs-foreign-biopharma-acquisitions/https://pharmadigest.net/zh/articles/2026-10-21-dcn1-ube2m-inhibitor-herg-reduction/https://pharmadigest.net/zh/articles/2026-10-21-fgfr3-selective-inhibitors-perspective/https://pharmadigest.net/zh/articles/2026-10-21-iwy357-pyrazine-carboxamide-antimalarial/https://pharmadigest.net/zh/articles/2026-10-21-sf-ga-pgp-substrate-to-nonsubstrate-redesign/https://pharmadigest.net/zh/articles/2026-10-22-cofolding-models-ligand-placement-vs-protein-conformation/https://pharmadigest.net/zh/articles/2026-10-22-gsk-fda-approval-hepatitis-b-functional-cure/https://pharmadigest.net/zh/articles/2026-10-22-inhaled-ddr-inhibitors-pyrrolopyrimidine-ipf/https://pharmadigest.net/zh/articles/2026-10-22-macrocyclic-cdk7-pyrazolotriazine-oral-selective/https://pharmadigest.net/zh/articles/2026-10-22-mkk3-non-atp-competitive-modulators-ulcerative-colitis/https://pharmadigest.net/zh/articles/2026-10-22-roche-hansoh-adc-portfolio-collaboration/https://pharmadigest.net/zh/articles/2026-10-22-roivant-positive-trial-non-infectious-uveitis/https://pharmadigest.net/zh/articles/2026-10-22-ttk-monovalent-degrader-monomethyl-fumarate-rnf126/https://pharmadigest.net/zh/articles/2026-10-22-ube2d2-electrophile-first-covalent-aminothiazole/https://pharmadigest.net/zh/articles/2026-10-22-yks-34-pde4b-selective-ipf/https://pharmadigest.net/zh/articles/2026-10-23-aimnet2-cpcm-ligand-strain-solvated/https://pharmadigest.net/zh/articles/2026-10-23-bcl9-beta-catenin-inhibitor-glioma/https://pharmadigest.net/zh/articles/2026-10-23-brd9-protac-mouse-crbn-vhl-species-gap/https://pharmadigest.net/zh/articles/2026-10-23-isomorphic-labs-valuation-ai-drug-discovery/https://pharmadigest.net/zh/articles/2026-10-23-lilly-metis-ai-lnp-delivery-deal/https://pharmadigest.net/zh/articles/2026-10-23-pyrroloquinoline-antitubulin-drug-resistant/https://pharmadigest.net/zh/articles/2026-10-23-sting-inhibitor-tetrahydropyrazolopyrazine-oral/https://pharmadigest.net/zh/articles/2026-10-23-tlr7-tlr8-pyridone-indole-antagonists-brd4-offtarget/https://pharmadigest.net/zh/computational/https://pharmadigest.net/zh/computational/archive/https://pharmadigest.net/zh/computational/archive/2026/09/https://pharmadigest.net/zh/computational/archive/2026/10/https://pharmadigest.net/zh/digest/2026-08-31/https://pharmadigest.net/zh/digest/2026-09-01/https://pharmadigest.net/zh/digest/2026-09-02/https://pharmadigest.net/zh/digest/2026-09-03/https://pharmadigest.net/zh/digest/2026-09-11/https://pharmadigest.net/zh/digest/2026-09-12/https://pharmadigest.net/zh/digest/2026-09-13/https://pharmadigest.net/zh/digest/2026-09-14/https://pharmadigest.net/zh/digest/2026-09-15/https://pharmadigest.net/zh/digest/2026-09-16/https://pharmadigest.net/zh/digest/2026-09-17/https://pharmadigest.net/zh/digest/2026-09-18/https://pharmadigest.net/zh/digest/2026-09-19/https://pharmadigest.net/zh/digest/2026-09-21/https://pharmadigest.net/zh/digest/2026-09-22/https://pharmadigest.net/zh/digest/2026-09-23/https://pharmadigest.net/zh/digest/2026-09-24/https://pharmadigest.net/zh/digest/2026-09-27/https://pharmadigest.net/zh/digest/2026-09-28/https://pharmadigest.net/zh/digest/2026-09-29/https://pharmadigest.net/zh/digest/2026-09-30/https://pharmadigest.net/zh/digest/2026-10-01/https://pharmadigest.net/zh/digest/2026-10-02/https://pharmadigest.net/zh/digest/2026-10-03/https://pharmadigest.net/zh/digest/2026-10-04/https://pharmadigest.net/zh/digest/2026-10-05/https://pharmadigest.net/zh/digest/2026-10-06/https://pharmadigest.net/zh/digest/2026-10-07/https://pharmadigest.net/zh/digest/2026-10-08/https://pharmadigest.net/zh/digest/2026-10-09/https://pharmadigest.net/zh/digest/2026-10-10/https://pharmadigest.net/zh/digest/2026-10-12/https://pharmadigest.net/zh/digest/2026-10-13/https://pharmadigest.net/zh/digest/2026-10-14/https://pharmadigest.net/zh/digest/2026-10-15/https://pharmadigest.net/zh/digest/2026-10-16/https://pharmadigest.net/zh/digest/2026-10-17/https://pharmadigest.net/zh/digest/2026-10-18/https://pharmadigest.net/zh/digest/2026-10-19/https://pharmadigest.net/zh/digest/2026-10-20/https://pharmadigest.net/zh/digest/2026-10-21/https://pharmadigest.net/zh/digest/2026-10-22/https://pharmadigest.net/zh/digest/2026-10-23/https://pharmadigest.net/zh/disclaimer/https://pharmadigest.net/zh/industry/https://pharmadigest.net/zh/industry/archive/https://pharmadigest.net/zh/industry/archive/2026/08/https://pharmadigest.net/zh/industry/archive/2026/09/https://pharmadigest.net/zh/industry/archive/2026/10/https://pharmadigest.net/zh/medchem/https://pharmadigest.net/zh/medchem/archive/https://pharmadigest.net/zh/medchem/archive/2026/09/https://pharmadigest.net/zh/medchem/archive/2026/10/https://pharmadigest.net/zh/pharmacology/https://pharmadigest.net/zh/pharmacology/archive/https://pharmadigest.net/zh/pharmacology/archive/2026/09/https://pharmadigest.net/zh/pharmacology/archive/2026/10/https://pharmadigest.net/zh/privacy/https://pharmadigest.net/zh/search/https://pharmadigest.net/zh/sources/https://pharmadigest.net/zh/terms/https://pharmadigest.net/zh/topics/https://pharmadigest.net/zh/topics/adc/https://pharmadigest.net/zh/topics/ai-ml/https://pharmadigest.net/zh/topics/antibodies/https://pharmadigest.net/zh/topics/cardiovascular/https://pharmadigest.net/zh/topics/cell-gene-therapy/https://pharmadigest.net/zh/topics/chemical-biology/https://pharmadigest.net/zh/topics/china-biotech/https://pharmadigest.net/zh/topics/clinical-readouts/https://pharmadigest.net/zh/topics/clinical-readouts/2/https://pharmadigest.net/zh/topics/covalent/https://pharmadigest.net/zh/topics/del/https://pharmadigest.net/zh/topics/dmpk/https://pharmadigest.net/zh/topics/drug-repurposing/https://pharmadigest.net/zh/topics/epigenetics/https://pharmadigest.net/zh/topics/fbdd/https://pharmadigest.net/zh/topics/financing/https://pharmadigest.net/zh/topics/gpcrs/https://pharmadigest.net/zh/topics/hit-finding/https://pharmadigest.net/zh/topics/immune-checkpoints/https://pharmadigest.net/zh/topics/immunology/https://pharmadigest.net/zh/topics/immunology/2/https://pharmadigest.net/zh/topics/infectious-disease/https://pharmadigest.net/zh/topics/infectious-disease/2/https://pharmadigest.net/zh/topics/kinases/https://pharmadigest.net/zh/topics/kinases/2/https://pharmadigest.net/zh/topics/lead-optimization/https://pharmadigest.net/zh/topics/lead-optimization/2/https://pharmadigest.net/zh/topics/lead-optimization/3/https://pharmadigest.net/zh/topics/licensing-partnerships/https://pharmadigest.net/zh/topics/licensing-partnerships/2/https://pharmadigest.net/zh/topics/m-and-a/https://pharmadigest.net/zh/topics/metabolic/https://pharmadigest.net/zh/topics/molecular-simulation/https://pharmadigest.net/zh/topics/neuroscience/https://pharmadigest.net/zh/topics/neuroscience/2/https://pharmadigest.net/zh/topics/oligonucleotides/https://pharmadigest.net/zh/topics/oncology/https://pharmadigest.net/zh/topics/oncology/2/https://pharmadigest.net/zh/topics/oncology/3/https://pharmadigest.net/zh/topics/oncology/4/https://pharmadigest.net/zh/topics/peptides/https://pharmadigest.net/zh/topics/ppi/https://pharmadigest.net/zh/topics/protein-degradation/https://pharmadigest.net/zh/topics/protein-degradation/2/https://pharmadigest.net/zh/topics/ras/https://pharmadigest.net/zh/topics/regulatory/https://pharmadigest.net/zh/topics/restructuring/https://pharmadigest.net/zh/topics/structure-based-design/https://pharmadigest.net/zh/topics/synthesis/https://pharmadigest.net/zh/topics/virtual-screening/